Using medical images acquired during routine clinical care for research purposes: a comprehensive medical informatics approach applied to the study of brain development from birth through 2 years of age as indexed by diffusion MRI by Roch, Vincent
 ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE 
SCHOOL OF LIFE SCIENCES 
 
 
 
Master's project in Life Sciences and Technology 
 
 
 
 
Using medical images acquired during routine clinical care 
for research purposes: 
a comprehensive medical informatics approach applied to 
the study of brain development from birth through 2 years of 
age as indexed by diffusion MRI. 
 
 
 
 
Carried out in the Laboratory for Neuroimaging Applications to Pain, Acupuncture and Placebo 
Research 
at Athinoula A. Martinos Center for Biomedical Imaging, Boston, MA, USA 
Under the supervision of Randy L. Gollub, MD, PhD 
 
 
 
Done by 
 
VINCENT ROCH 
 
 
 
Under the direction of 
 
PROF. Nouchine Hadjikhani 
 
In the laboratory of Social Cognitive Neurosciences 
EPFL 
 
 
 
 
 
LAUSANNE, EPFL 2011 
  
  Contact information 
   
 
 
 
Contact information 
 
 
Vincent Roch 
Route de la Borette 14 
1890 St-Maurice 
Valais 
Switzerland 
 
Swiss phone   :   +41 79 785 02 62 
US pone   : +1 857 264 99 20 
 
e-mail addresses : vincent.roch@epfl.ch  
vincentr@nmr.mgh.harvard.edu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Boston, 4th of August 2011                   Vincent Roch 
  
  Acknowledgments 
   
 
 
 
Acknowledgments 
 
 
I would like to sincerely thank Pr. Nouchine Hadjikhani for accepting to be my master project 
advisor at EPFL, for following me throughout this project, and for her availability and support. She 
kindly introduced me to Dr. Randy Gollub who generously accepted me in her laboratory where I 
carried out this work for the last year. Despite her very busy schedule, Dr. Randy Gollub was always 
available to lend her guidance when I needed help and she always encouraged me, especially in 
difficult times. She notably allowed me to accomplish this work by introducing me to 
knowledgeable researchers who were invaluable all the way through this project.  
My acknowledgments go to Dr. Ellen Grant, initiator of the Baby Brain project, whose well-
informed expertise was crucial for the success of this project. I want to also thank Lilla Zollei and 
Rudolph Piennar who kindly and regularly helped me with processing tools and script coding.  
I am grateful to the mi2b2 team and its Principal Investigators, Dr. Shawn Murphy and Dr. Randy 
Gollub for allowing me to participate in their weekly meetings and for allowing me the honor of 
using the first version of the prototype of mi2b2 software. I want to particularly thank Bill Wang, 
Chris Herrick and David Wang from the mi2b2 team for helping me retrieve all the medical images 
using the newly developed software. 
I also would like to express my gratitude to all my lab colleagues who helped me and supported 
me in different ways. Specifically, Rita Loiotile for Unix scripting, Karin Jensen and Marco Loggia for 
statistical analyses, and Rosa Spaeth for the final revision of the thesis. My particular gratitude 
goes to Alexandra Cheetham who took care of all administrative procedures and who carefully 
revised the first draft of my thesis with helpful suggestions. 
Finally, I would like to express my gratitude to all my friends, relatives and close family who 
have constantly supported me in my study, with a special thanks to my Parents, Esther and Jean-
Didier Roch, for their unconditional encouragements. 
 
This work was supported by National Institutes of Health, National Center for Research 
Resources (NIH-NCRR) as an ARRA supplement to Harvard Medical School’s Clinical Translational 
Science Award (the Harvard Catalyst) under the “Medical Imaging Informatics Bench to Bedside 
(mi2b2) grant NCRR (1 UL1 RR 025758-01) and the Biomedical Informatics Research Network (1 
U24 RR 025736-01). 
 
  
  Summary 
   
 
Summary 
 
 
Biologic variability and dramatic changes of brain development in children aged 0 to 2 years 
make it challenging to accurately detect subtle abnormalities in single Magnetic Resonance 
Imaging (MRI) scans. Diffusion MRI (dMRI) indices such as Apparent Diffusion Coefficient (ADC) are 
reliable measures of water content in the brain and thus an excellent surrogate marker for brain 
development. Developing robust age-specific diffusion biomarkers for quantitative measurement 
of normative brain evolution would enhance our ability to detect subtle alterations due to tissue 
injuries or neuropathological disorders. Obtaining significant numbers of normative MRI scans for 
this age group means redirecting clinical data from hospital databases for research purposes. 
Therefore, this pilot project demonstrates the feasibility of identifying, retrieving and analyzing 
pediatric clinical dMRI data to investigate normal brain development from birth to 2 years. 
Research Patient Data Registry (RPDR) at Massachusetts General Hospital (MGH) was used to 
collect patient medical information and identify healthy children according to radiology reports. 
Corresponding MRI data were retrieved from MGH Picture Archiving and Communication System 
(PACS) using the prototype of Medical Imaging Informatics Bench to Bedside (mi2b2) software. A 
specific pipeline was created to handle the volume of studies and extract technical scan 
information used to identify comparable diffusion series; 193 studies were used for analysis. 
Two markers, whole brain average of ADC and Fractional Anisotropy (FA) values (WBAADC and 
WBAFA), were computed for each patient, their age-evolution across patients was investigated with 
different models. WBAADC and WBAFA seem to exhibit biexponential decay and increase 
respectively and might be gender-specific. 
These results have clinical implications for potentially determining the health status of an 
unknown individual, and research utility for continued development of these tools. 
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1. Introduction 
 
This particular work using clinical data to study newborn and infant brain development emerged 
a few months ago, resulting from the convergence of two complementary on-going research 
projects. Specifically, the Medical Imaging Informatics Bench to Bedside (mi2b2) project 
implemented at MGH and Dr. Ellen Grant’s work on pediatric data (see People section, part 8.3). 
My work has been made possible by this union because the mi2b2 project facilitates retrieval of 
medical images, while Dr. Ellen Grant’s work justifies the usefulness of mi2b2. Let me explain: 
 
Hospital databases are real gold mines in terms of the amount, quality and specificity of 
biomedical data they contain. For the last decade, medical images acquired during routine clinical 
care often equal the quality of the best research imaging data sets available worldwide. Most 
importantly, the plethora of clinical scans vastly exceeds the scope of research data and includes 
much larger and more diverse patient populations, including normal cohorts who are imaged to 
rule out pathological conditions. However, until recently, accessibility to and secondary use of 
clinical imaging data for research purposes has been severely limited due to complex 
administrative, legal and technical reasons (Gollub and Turner, 2010). Recently, several projects 
aiming to facilitate the transition of clinical data to translational research have been initiated. 
Notably, the Informatics for Integrating Biology and the Bedside (i2b2) project whose software, 
when implemented in hospitals, can be used to find sets of wanted patients from electronic patient 
medical record data, while preserving patient privacy through a query tool interface (Murphy et al., 
2007 ; Murphy et al., 2010). Similar tools have also been specifically developed in certain 
institutions, like Partners Research Patient Data Registry (RPDR) tool (see part 3.2.1), enabling 
affiliated and authorized researchers to identify and access medical information of any patients of 
interest within the institution. Despite the increasingly widespread use of such tools, neither i2b2 
nor RPDR managed medical images. With funds from an American Recovery and Reinvestment Act 
(ARRA) Administrative Supplement to the Harvard Catalyst, a prototype of the mi2b2 software has 
been deployed by a devoted team headed by Dr. Randy Gollub and Dr. Shawn Murphy (see People 
section, part 8.3). This software provides the infrastructure and regulatory policies necessary to 
locate and retrieve medical images from clinical repositories known as Picture Archiving and 
Communication Systems (PACS) (Murphy, Marcus et al, 2011)1 (see part 3.2.3).  
Soon that the infrastructure to identify and retrieve medical imaging data will be ready to 
deliver to affiliated researchers (actually, mi2b2 software is not publically available yet, I had the 
honor of using the first prototype version).  A critical need during this development process was to 
have a prototype project requiring medical images: this is where Dr. Ellen Grant’s work comes in. 
She proposed that the use of such medical data would be of particular value and interest in regards 
to Magnetic Resonance (MR) neuroimaging in pediatric patients. In this population, age related 
changes in MR contrast properties are so dramatic that they compromise interpretation of 
pathological changes (Sagar and Grant, 2006 ; Rodrigues and Ellen Grant, 2011 ; Utsunomiya, 2011) 
(see part 2.4). Investigating normal pediatric brain development and extracting quantitative 
measurements would support radiologists in their ability to detect subtle alterations present in 
                                               
1 Murphy SN, Marcus D, et al. New Tools for Integrating Clinical Images into Research Studies. Presented at Society for 
Imaging Informatics in Medicine. 2011. 
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conditions such as metabolic disorders or tissue injury (ischemic, necrotic, gliosis, edema). These 
subtle differences, if detected, would greatly improve radiologists’ ability to diagnose such 
conditions based on clinical imaging, monitor treatment responses and hopefully improve 
outcomes2. Research has shown (see part 2.2) that myelination undergoes dramatic changes in 
children from birth to two years of age (Deoni et al., 2011). Apparent Diffusion Coefficient (ADC) 
maps and other Diffusion Weighted Imaging (DWI) indices are reliable measures of water content 
in the brain and thus an excellent surrogate marker for development of myelination over time 
within a subject (see part 2.1). Diffusion images, and their corresponding volumetric T1 and 
isotropic DWI data, are already available from the clinical archives in our institution (MGH) for 
newborns and young children. These images are of good enough quality for this project. The 
quantity of data available in MGH PACS is significantly larger than what has been available so far in 
research due to legal and technical issues in scanning newborns and infants for research purposes 
only. This highlights the importance and the usefulness of using medical imaging data for our 
purposes and in this context. 
In this project, I am going to demonstrate the feasibility of identifying, retrieving, and analyzing 
pediatric clinical multimodal MRI data, using the available tools and the prototype mi2b2 software. 
The aim of this project is to study normal human brain development from birth through 2 years of 
age as indexed by diffusion MRI.  
The overall workflow of this project is displayed in Figure 1. In order to begin this project, I first 
had to obtain the necessary authorization from the Institutional Review Board (IRB) (see chapter 
3.1) to collect MRI data from MGH PACS (2) and corresponding medical information (3). The RPDR 
tool available at MGH was used in order to request medical information (4) for any patients aged 0-
2 years who had a clinical brain MRI scan acquired after the year 2000 (when DWI scans were 
added to the standard acquisition sequences see part 3.2.1). Mining this medical information, 
which was retrieved in Microsoft Access database format, enabled me to refine the query and 
individually identify patients of interest who met the selection criteria (5) (see 3.2.2). MRI data 
from the selected patients was requested from PACS through the newly developed prototype 
mi2b2 software (6) (see 3.2.3) and sent through a pipeline (developed by myself) that 
automatically reformats, organizes, converts (7) and extracts additional information from the 
newly acquired imaging data (8) (see 3.2.4). From there, MRI images needed for the 
developmental study were identified according to modality (e.g. diffusion images) and sequence 
parameters to ensure their comparability (9) (see 3.2.5). Finally, I used diffusion indices (i.e. ADC 
and FA) to further analyze the selected data in order to investigate age-specific evolution of normal 
human development from birth through 2 years of age (10) (see 3.3). 
I will start this work with a quick overview of the current knowledge in the field of diffusion 
imaging (part 2.1), its application to brain development (part 2.2 and 2.3) and its clinical relevance 
(part 2.4). A step-by-step description of the materials and methods outlined above will then be 
thoroughly presented in part 3 followed by results from database mining and data analysis. Finally, 
I will finish this thesis by discussing the obtained results before concluding (parts 5 and 6 
respectively). 
                                               
2 Project’s IRB application 
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Figure 1: Patients are scanned in the hospital (1) and MRI data are stored in PACS (2). Radiologists access the images 
and their resulting observations (as well as all medical information regarding patients) are stored and organized in 
RPDR (3). The RPDR query allows the retrieval of this medical information in Microsoft Access database format (4).  
This database is used to identify patients meeting certain criteria (5) and the corresponding list of identifiers is sent 
to mi2b2 software in order to retrieve the related images (6). The BB-pipeline then automatically organizes the data 
(7) and extracts technical information that is added to the Access database (8). The resulting database is used to 
precisely identify and select comparable images with modalities of interest (9) that are used for further data analysis 
(10). 
 
The current project is the culmination of my master’s work; it has also been integral to both the 
mi2b2 project and Harvard Catalyst. The results that I have obtained, as well as the outcomes of 
troubleshooting the problems that I encountered with the software, have helped the mi2b2 team 
to improve the utility and the impact of their new software for retrieving clinical data to improve 
translational investigations. Additionally, my results have been included as preliminary data in a 
five year RO1 grant application submitted in June 2011 requesting funds to further for the 
development of mi2b2 and to develop a novel Harvard Catalyst Radiological Decision Support 
(RDS) Toolkit. Specifically, the grant proposes to develop an extensible framework to support a 
specific Pediatric MRI module based on neurodevelopmental MRI atlases for structural (T1 and T2) 
and diffusion tensor imaging (DTI) data from brain scans of patients without neuropathology.  
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2. Background 
 
2.1. Diffusion Magnetic Resonance Imaging (dMRI) 
 
dMRI is one of many imaging modalities obtainable using a standard MRI scanner. This 
technique is based on the attenuation of the MR signal due to water motion (diffusion) within 
different parts of the brain.  
In order to provoke this attenuation, an additional gradient, called a Diffusion Weighted (DW) 
gradient is applied during a typical gradient or spin-echo pulse sequence (see Figure 2, taken from 
Mori and Zhang, 2006). 
 
 
Figure 2: Standard spin-echo sequence with the additional gradient (the other gradients along the x, y and z 
directions for spatial encoding are omitted for simplification). The b-value is an experimental parameter which 
depends on the length, height and timing of the DW gradient. 
 
Water molecules that diffuse along the direction of this DW gradient within the time between 
the excitation and the data sampling induce a loss in phase coherence, leading to the attenuation 
of the signal (see Figure 3, taken from Mori and Zhang, 2006). As a result, the more water 
molecules that are able to diffuse along the direction of the gradient, the more phase coherence 
loss will be induced, and the more signal loss will be observed.  
 
 
 
Figure 3: When molecules of water diffuse along the direction of the gradient (horizontal yellow arrows), a loss in 
phase coherence is noticed after the rephasing step.  
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For instance, the MR signal of a voxel containing white matter tracts that are parallel to the DW 
gradient will be lower than the signal of voxel containing white matter tracts running perpendicular 
to the gradient. In fact, in the former case, water molecules can easily diffuse in the direction of 
the gradient. However in the latter, water diffusion in the direction of the gradient will be limited 
by the cell membrane resulting in less signal attenuation (see Figure 4, taken from Hagmann et al., 
2006). 
 
 
 
Figure 4: Myelin, cell membrane and microtubules/neurofilaments restrict water diffusion in perpendicular 
directions leading to less signal attenuation. 
 
The attenuation of the signal can be modeled by the following equation: 
 
bDeSS  0                 (1) 
 
where S is the DW signal, S0 is the signal without any DW gradient, b is the parameters of the DW 
gradient and D is the ADC. 
D corresponds to the diffusivity of water molecules along the direction of the DW gradient, thus 
D is the value we want to obtain. Since we have one only equation but two unknowns (S0 and D) 
for one pulse sequence with one b value, we need a second pulse sequence with different b-value 
in order to calculate D which is constant across sequences (D is an intrinsic property of the brain 
for a determined volume). Now we have two equations: 
 
DbeSS 101
  and DbeSS 202
     (2) and (3) 
 
and by simply dividing equation (2) by equation (3), taking the natural logarithm and rearranging 
the resulting expression, we can calculate D: 
 
12
21 )ln()ln(
bb
SSD


       (4) 
 
If we calculate this diffusion coefficient at each voxel, we can calculate a map of the diffusion 
coefficient, the so-called ADC map, in which the intensity of each voxel is proportional to the 
extent of diffusion (Mori and Zhang, 2006). One of the two images is often referred as the 
reference image and has in general a lower b-value; this b-value is commonly referred as b0, b-zero 
or low-b. 
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At this stage it is worthwhile to emphasize that D gives us information about the diffusivity of 
water in one direction only, the direction of the DW gradient. In order to get a more precise and 
complete estimation of the water diffusion information, these steps have to be replicated several 
times changing the direction of the DW gradient each time. Doing so, we can obtain a specific D for 
each direction. From these D-values (at least six from linearly independent directions) a 3x3 tensor 
matrix can be estimated using multiple linear least squares methods (Basser et al., 1994) or non-
linear modeling (Alexander et al., 2007). This matrix can be represented by a tensor (an ellipsoid) 
calculating its eigenvectors and the corresponding eigenvalues (λ1, λ2, λ3) which give an indication 
about the directionality of the diffusion; this method gives rise to Diffusion Tensor Imaging (DTI) 
(Le Bihan et al., 2001).  
From all these values, different calculations can be computed in order to get some specific 
information about the diffusivity of the water molecules. Fractional Anisotropy (FA) is among the 
most commonly used calculations: 
 
      
 232221
2
13
2
32
2
21
2 



FA      (5) 
 
The FA ranges from 0 to 1 which gives an index of the strength of the directionality: 1 being an 
anisotropic diffusion (water molecules tend to diffuse in one specific direction) and 0 being an 
isotropic one (water molecules move in any direction indiscriminately, i.e. λ1 = λ2 = λ3). Additional 
values that can be calculated to obtain more information about the diffusion include the Mean 
Diffusivity (MD, Dave, ADCave, D¯ or Trace/3) Axial Diffusivity (AD), and Radial diffusivity (RD) 
corresponding respectively to the average of the eigenvalues ((λ1 + λ2 + λ3)/3), the largest 
eigenvalue (λ1), and the average of the smaller two eigenvalues ((λ2 + λ3)/2). These calculated 
values give an indication of the properties of water diffusion within the brain, which, in turn, 
reflect underlying biophysical characteristics of the brain (myelination, axonal density, etc.).  
Some confusion can emerge using the term ADC; depending on authors, ADC can either make 
reference to the ADC map (see above) or to MD. To avoid such misunderstandings, I will use MD, 
Dave, ADCave, D¯ or Trace/3 interchangeably in this thesis, and when referring to images 
corresponding to diffusion coefficients in only one direction, I will use the term “ADC map”; 
additionally, D in equation (1) to (4) will be referred to as “ADC” only. 
One last point is important to understand. We saw earlier that D in equation (1), calculated in 
equation (4) is constant across sequences because it is an intrinsic property of the brain for a 
determined volume, namely, the properties of water diffusion occurring within a particular voxel. 
However, evidence from Ogura et al., showed that ADC value measurements actually depend on 
the choice of b-values by applying different b-values to different control mediums (see Figure 5, 
taken from Ogura et al., 2011). Ogura et al.  also emphasized that choosing long TR and short TE 
was effective for accurate measurement of ADC (Ogura et al., 2011).  
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Figure 5: ADC values are calculated for different b-values. Higher b-values have more influence on ADC than lower b-
values 
 
Thus, this issue has to be taken into account when comparing data acquired with different 
parameters, and this will be of special concern when selecting our diffusion data of interest (see 
part 3.2.5). 
 
2.2. Diffusion MRI of brain development 
 
As we have seen, diffusion imaging is sensitive to the motion of water molecules within the 
brain, called diffusivity. Diffusivity depends on the internal structure and composition of the brain, 
such as axonal organization or myelination, and thus makes this modality especially useful for 
exploring maturation of the brain. Indeed, certain diffusion indices seem to be even more sensitive 
to internal brain changes than conventional MRI (T1- or T2-weighted imaging) in the context of 
either maturation processes or brain damage (Hüppi and Dubois, 2006). For example, an early 
study by Miller et al. emphasized the advantage of using ADC and diffusion anisotropy over the 
conventional MRI techniques, showing that diffusion imaging could be more objective and 
sensitive to detect subtle developmental changes. However, their study was based on only a few 
individual subjects from 26 weeks to 6 years of age (Miller et al., 2003). 
The combined improvements in diffusion image acquisition parameters and MRI scanner 
hardware during this last decade have enabled more sensitive image data to be collected in less 
time and have allowed researchers to envision using diffusion MRI more systematically in 
developmental research. As this modality have become more reliable, available and standardized, 
an increasing number of research groups have started to investigate brain development in terms of 
the evolution of diffusion indices (mainly MD, FA and eigenvalues) in different Regions of Interest 
(ROIs). However, age ranges, numbers of subjects, diffusion indices, and experimental protocols 
vary greatly across studies. For example, one study established ADC values in normal fetal brains 
(22-35 weeks) in utero in 15 fetuses (Righini et al., 2003), whereas another study attempted to 
create an MRI/clinical/behavioral database from 500 children aged 7 days to 18 years using several 
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modalities and indices (structural/volumetric analysis, MR spectroscopy, DTI among others) (Evans 
and , 2006 ; Almli et al., 2007). 
Most of the studies have tried to establish a time-related evolution of different diffusion indices 
throughout life with different models. Westlye et al. aimed to outline age trajectories of DTI indices 
within 8-85 years in 430 healthy subjects using nonparametric regressions. The study concluded 
that after accelerated changes during childhood and early adulthood, DTI indices reach a plateau in 
the early 30s, followed by a slow change until middle-age and ended by a rapid change in the latest 
part of life (Westlye et al., 2010).  This same age related pattern of change was evident across all 
their ROIs. Other groups restricted their studies to more specific age ranges using different models. 
The group of Asato et al., for example, investigated 114 subjects ranging from 8 to 28 years in 
order to characterize specific white matter integrity changes during adolescence using DTI; RD 
seemed to decrease across different age groups (from childhood to adolescence, and from 
adolescence to young adulthood) in distinct brain regions (Asato et al., 2010). Snook et al. also 
focused their attention on the regional changes in the maturation of the brain from childhood (8-
13 years) to young adulthood (21-27 years) in 60 subjects. They highlighted either increases or 
decreases in MD or FA indices depending on the brain region (see Figure 6 for an example of 
negative correlation trends of MD in 6 different ROIs, taken from Snook et al., 2005). Their findings 
suggested that the microstructural development of the brain persists throughout adolescence, 
something that would have been much more difficult to observe with conventional T1-weighted 
MRI (Snook et al., 2005). 
 
 
 
Figure 6: Correlation plot between the ages and the MD values in 6 different ROIs (Trace/3 ADC is equivalent to the 
MD). 
 
Three other papers deserve to be mentioned. The early study by Murkherjee et al. tracked the 
time course of Dave and FA values in 153 subjects (age range, 1 day to 11 years) in different ROIs 
and observed a biexponential decay of Dave (see Figure 7, taken from Mukherjee et al., 2001) and a 
more complex increase in FA with age in gray and white matter (Mukherjee et al., 2001). 
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Figure 7: Transverse MR images in five children 17 days to 10 years old at 2 different levels (left picture) and the 
time course plot of Dave in the Posterior Limb of the Internal Capsule (PLIC). The decay of Dave in early developmental 
stage can clearly be noticed in both figures (e.g. change in brightness from very bright to dark in left picture).  
 
Later work by Hermoye et al. in a more restricted age range (23 patients, aged 0-54 months) 
obtained similar results (see Figure 8A, taken from Hermoye et al., 2006). Once again, these results 
confirm that diffusion imaging is of special relevance when studying brain development in the early 
stages of life, since its different indices (Dave and FA) reveal the greatest changes within this period. 
Subsequently, Löbel et al. observed similar changes for ADC and FA investigating 72 patients aged 3 
weeks to 19 years retrospectively. They found that logarithmic functions best described the data 
(see Figure 8B taken from Löbel et al., 2009). 
 
A B
 
 
Figure 8: Time courses for FA and Dave in the Posterior Limb of the Internal Capsule (PLIC) and the splenium of the 
Corpus Callosum (sCC) as shown by Hermoye et al. (2006) (A). Similar time course in Löbel et al. (2009) papers for 
the PLIC and the inferior frontal white matter (B); note the logarithmic fitting curve in red. Comparing the Dave time 
evolution with the one of Figure 7, we note a similar pattern for the PLIC ROI. 
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Finally, it is important to remember that these diffusion indices only give information about 
the diffusivity of water molecules within the brain, and even though diffusivity depends on the 
underlying tissue structure (myelination, axonal density, etc.), we should be careful not to interpret 
the results as direct measurements of underlying biophysical properties (Wheeler-Kingshott and 
Cercignani, 2009) as may be the case in some studies. 
 
2.3. Brain atlases of healthy babies and children 
 
Before considering methods for the creation of atlases for diffusion indices, crucial pre-
processing image analysis steps must be addressed. One of them, brain normalization, is of key 
importance when investigating different subjects within a cohort. In fact, by observing raw images 
from different subjects, inter-individual differences in terms of brain size, shape or internal 
structure are evident even to the eye. These individual differences render the data challenging to 
use to make meaningful comparisons. The normalization step consists of transforming the MRI 
data from an individual subject to match the spatial properties of a standardized image, such as an 
averaged brain derived from a sample of many individuals3. 
In this context, research groups have tended to use common normalization schemes called 
stereotaxic spaces in order to facilitate inter-laboratory communications. The most widely used 
stereotaxic spaces are the Talairach space (derived from a single brain of an elderly woman) or the 
Montreal Neurological Institute (MNI) space (derived from the average of MRI structural images 
from more than 100 hundred subjects). However, most of the tools used to transform brains in a 
standard frame have only been developed to process adult brains and thus cannot directly be used 
with data from babies or children. 
Recently, different groups have tried to tackle this problem in order to be able to investigate the 
brains of babies and children in a more robust way. In 2002, Wilke et al. compared the linear 
scaling parameters and the deformations from the non-linear spatial normalization obtained from 
both a standard adult and a custom pediatric template with T1-weighted images, pointing out that 
caution should be used when describing functional activations in children on the basis of adult data 
such as Talairach coordinates (Wilke et al., 2002). The next year, Wilke et al. came to the same 
conclusion comparing their newly created pediatric templates and a priori brain tissue data from 
148 healthy children (age range 5-19 years) with standard adult data available within SPM 
software4 (SPM99): concluding again that caution should be used when analyzing pediatric brain 
data using adult a priori information (Wilke et al., 2003). 
Further investigation by Kazemi et al. was done on younger subjects using an updated version of 
SPM (SPM2). Seven newborns (gestational age range 39-42 weeks) were used to create a neonatal 
atlas template. The following is a summary of their protocol used to generate a brain template of 
newborns. They first selected a reference image and positioned it in a standard way (anterior 
commissure at the origin of the line connecting the anterior with the posterior commissure in the 
horizontal plane). Subsequently, an affine registration was applied to all the other images in the 
data set with respect to the reference image in order to correct the position and global shape 
                                               
3 Huettel, Song & Mcarthy (2009) Functional Magnetic Resonance Imaging, Sinauer Associates (Sunderland, MA) 
4 Statistical Parametric Mapping, Wellcome Trust Centre for Neuroimaging, London, UK.  
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differences. These registered images were then nonlinearly normalized to the reference image5 
and the average deformation was applied to them. At this point, the template was generated by 
averaging these newly obtained images. The last step was to use this generated template as the 
new reference and the entire process was replicated in order to reduce the bias induced by the 
first reference image. They came to the conclusion that using a data set-specific template for 
alignment of neonatal images taken from this data set resulted in an improved normalization 
process, compared with the results obtained with the use of an a priori adult template or even 
with the use of an a priori pediatric template such as the Cincinnati Children’s Hospital Medical 
center (CCHMC) Pediatric Brain Template (Kazemi et al., 2007). In 2008, Altaye et al. completed the 
same kind of study with different processing steps and used a larger cohort of 76 infants ranging in 
age from 9 to 15 months using SPM5. They used their results not only for normalization, but also 
for segmentation of the infant brain (Altaye et al., 2008). Meanwhile, the same group developed a 
toolbox for creating customized pediatric templates called “Template-O-Matic” for the SPM5 
image data processing suite. They came to the conclusion that their tool was of special utility for 
customized reference data generation and for image processing of an “unusual sample”, such as 
children or elderly subjects (Wilke et al., 2008). 
All of the works described above were done on T1-weighted images and were not applied to 
DWI or DTI. To date, I have not come across any papers working on the creation of diffusion atlases 
for babies/children that simultaneously assess the efficiency of the method used to generate the 
template, as was the case in the studies presented above. Current diffusion studies (Bartha et al., 
2007 ; Faria et al., 2010) have been more interested in investigating the time course of different 
diffusion indices (see 2.2) than in the generation of a DWI/DTI template. In order to normalize their 
data, they used already available tools such as the Automated Image Registration (AIR) software 
with an a priori reference template such as the ICBM-DTI-81 template, a template that is based on 
probabilistic tensor maps obtained from 81 normal adult subjects acquired under an initiative of 
the International Consortium of Brain Mapping (ICBM)6. As indicated in the previous paragraph, 
this might not be the best solution since the a priori data set used to normalize the brains of 
babies/children in these studies originated from adult subjects. 
 
2.4. Clinical applications of diffusion imaging 
 
Diffusion imaging is not only of special interest and sensitivity for detecting and observing subtle 
changes during brain development, as indicated above, but also in detecting and observing general 
changes within the brain. This means that changes caused by strokes, traumatic brain injuries, 
abnormal development or diseases affecting brain integrity could also be detected with the help of 
diffusion measurements. Actually, these different measurements are currently used in Radiology 
departments to detect brain abnormalities in adults as well as in babies and children. I had the 
chance to spend one afternoon with Dr. Grant in within the Pediatric Radiology Center at 
Children’s Hospital Boston to observe how they analyze the medical imaging data to arrive at a 
diagnosis. I can confirm that diffusion data are used for diagnostic purposes. Currently, this 
modality is used as a complement to other modalities (e.g. T1 and T2 weighted MRI). 
                                               
5 Using the method presented by (Ashburner and Friston, 1999) 
6 http://www.loni.ucla.edu/Atlases/Atlas_Detail.jsp?atlas_id=15 
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It seems that diffusion imaging could possibly be a more appropriate tool to detect early effects 
of brain injuries than conventional MRI since water diffusion changes are an early indicator of 
cellular injury. This could be of particular importance in infants in the context of administration of 
neuroprotective therapies (Hüppi and Dubois, 2006). In their 2006 review, Pallavi Sagar and Ellen 
Grant described the known pathophysiologic processes linked with changes in ADCs (increase or 
decrease) and described the pattern and time course of DWI and ADC findings in a number of 
pediatric disorders (Sagar and Grant, 2006). In their 2011 papers, Katyucia Rodrigues and Ellen 
Grant emphasized the importance of using DWI and ADC images concurrently with conventional 
MR images in order to facilitate an accurate diagnosis. This is even more relevant for immature 
brains where incomplete myelination can render injury detection more difficult if only screened on 
T2-weighted images (Rodrigues and Ellen Grant, 2011). 
Unpublished notes from Dr. Ellen Grant point out some limitations on visually detecting brain 
injuries in early development without quantitative normative data for comparison. For example, 
gestalt visual diagnosis of brain injury is difficult in the developing brain due to the rapidly 
changing appearance of normal, making it difficult for even experienced neuro-radiologists to 
detect subtle abnormalities when relying on visual interpretation alone. In the case of neonatal 
hypoxic ischemic brain injury, subtle injuries can be missed on DTI because areas prone to injury 
normally have lower diffusivity than adjacent areas due to developing myelination (Figure 9 a, d). 
Injury causes a further decrease in diffusivity (Figure 9 e) and therefore knowing when the 
diffusivity is too low can be difficult and can lead to variability in clinical reads.  
 
 
 
Figure 9: Top Row T2 weighted images. Bottom row Apparent Diffusion Coefficient  (ADC) Maps. Normal neonates 
have lower T2 signal and ADC in regions that are undergoing myelination (arrows in a, d respectively). Neonates 
with hypoxic Ischemic Injury have lower ADC in the same regions (arrows in e). In normal older children with fully 
myelinated brain regions (c, f) the ADC image is homogeneous (f) as compared to the normal neonate (d) making 
areas of abnormally decreased ADC easier to detect in older children because fully myelinated brain regions have 
uniform diffusivity. Therefore injuries are more easily detected by visual inspection alone as they appear as 
deviations on a homogeneous background.7 
 
                                               
7 Unpublished figure from Dr. Ellen Grant 
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However, when quantitative DTI data is compared between normal and those diagnosed 
clinically with hypoxic ischemic injury, significant differences are obtained and these differences 
correlate with outcome providing potential prognostic significance (Zarifi et al., 2002 ; Vermeulen 
et al., 2008)”.8 
 
In summary, diffusion imaging may be very well suited to the investigation of early brain 
development and to the construction of age-specific markers/atlases for newborns or infant, since 
the diffusion indices are sensitive to dramatic changes during this period. In addition, the 
sensitivity of diffusion indices such as MD or FA to detect brain “abnormalities” makes this 
modality particularly suitable in this context if quantitative normative data can be obtained and 
used as a support tool to help radiologist in detecting brain injuries in young patients. 
                                               
8 Unpublished notes from Dr. Ellen Grant 
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3. Materials and methods 
 
3.1. Institutional Review Board (IRB) approval 
 
Prior to any research studies on human subjects, official authorization given by an IRB has to be 
obtained to ensure the protection of the rights and welfare of any research subjects (Hart and 
Belotto, 2010).  In the United States, this is a federal regulation that any research institution 
conducting human subjects research must comply with. This committee is chosen by each 
institution and has to follow certain guidelines notably dictated by the Food and Drug 
Administration (FDA).  
Within MGH, the IRB is known as the Partners Human Research Committee (PHRC). “The PHRC 
must approve all human-subject research conducted by a Partners-affiliated investigator. Human-
subject research is a systematic investigation designed to develop or contribute to generalizable 
knowledge where an investigator obtains data on individuals either through direct 
intervention/interaction or through the use of identifiable private information (medical records) or 
specimens”9. Under these conditions, the current project falls under IRB approval since data on 
individuals through the use of identifiable private information needs to be collected. 
This project was approved in November 2010 under the title: “Diffusion ADC atlas of normal 
development in children (ages birth-2 years and 2-20 years)”. It is sponsored by the mi2b2 grant 
from the National Institutes of Health - Center for Research and Resources (NIH-NCRR) as a 
supplement to Harvard Medical School’s Clinical Translational Science Award (the Harvard 
Catalyst). Our IRB application briefly describes the purpose of the research and its significance, the 
type of data to be collected (in our case, medical record review including images of any children 
(aged 0-20 years) who had an MR image data set collected at MGH from 2000 to the present 
(rolling forward) until IRB expires), the security measures taken to protect patient personal 
information, and finally the study staff approved to have access to this data. Additionally, everyone 
on the IRB has to be CITI10-certified meaning that they have passed specific training modules 
related to research on humans and its legal implications. 
 
3.2. Database mining (Medical Informatics) 
 
Retrieving appropriate medical imaging data from hospital databases requires patience and 
multiple steps through which I was able to gradually refine selection criteria. Each step, from 
retrieving the scans for a patient of interest, to finding specific MRI series for the proposed 
research, will be thoroughly described in the following chapters. Working with large amounts of 
data requires some organization to avoid the risk of drowning in the huge amount of available 
data. I have completed each phase of the process described below, and I designed each step 
specifically to facilitate the search for information, automating as many processing steps as 
possible. Here is a brief step-by-step overview:  
                                               
9 http://healthcare.partners.org/phsirb/abouthrc.htm 
10 Collaborative Institutional Training Initiative (CITI), https://www.citiprogram.org/ 
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The first step required the use of the Research Patient Data Registry (RPDR), a database specific 
to MGH, BWH and several other Partners institutions. RPDR stores all patient information gathered 
at one of these hospitals. The RPDR web tool allows the request of this information for any 
patients who fulfill specific predefined criteria (see part 3.2.1).  
Patient information was then retrieved in Microsoft Access Database format that enabled the 
refining of patient criteria selection. At this point, individual patient information was available, 
allowing the identification of patients of interest whose images needed to be retrieved (3.2.2). 
After having designated the patients of interest, I was able to use their Medical Record Number 
(MRN, unique hospital-specific identifier for each patient) to query the imaging data from the 
Picture Archiving and Communication System (PACS) of the chosen institution, using the mi2b2 
software prototype currently under development (3.2.3).  
The results of this query provided information about the images and their corresponding 
detailed specifications (modalities used, pulse sequences, etc.) that are stored in Digital Imaging 
and Communications in Medicine (DICOM) format. DICOM is the universal format used in PACS 
image storage, which contains not only the images, but also technical acquisition information 
about these images. The raw data retrieved from PACS first had to be reorganized (in terms of 
file/directory names, directory structure, etc.) in order to facilitate further work on them (3.2.4). At 
the same time, I automatically extracted MRI image details (sequence parameters, image 
resolution, etc.) from the DICOM headers and added them to the Microsoft Access Database to 
complete it with technical information that was not available from the RPDR query (3.2.5). 
Once the data were well organized, including all pertinent information, I was able to, in couple 
of mouse clicks, instantly execute a request such as the following: “Give me the ADC volumes of 
any patients who were scanned at the age of 30 to 60 days whose corresponding radiology reports 
don’t mention any major brain abnormality”. This type of request allowed further research to be 
conducted on specific data modalities from specific populations (3.2.5).  
Let’s now have a look into each step in more detail. Every step is described in light of the 
specific aims of my project, namely to find and retrieve all the data from patients who had an MRI 
scan of the brain acquired on or after the year 2000, who were aged 0 to 2 years at the time of the 
scan and whose corresponding radiology reports reveal no major brain abnormality (we limited our 
query to only those scans collected after the year 2000 when we know from our collaborator, Dr. 
Ellen Grant, the standard acquisition protocols began to include diffusion weighted images). 
 
3.2.1. RPDR query 
 
RPDR is a database specific to MGH, BWH, and several other Partners institutions that stores all 
visits, procedures, diagnoses, and patient information gathered at any one of these hospitals. It 
notably contains more than 5 million Partners Healthcare patients. RPDR allows users to perform 
IRB approved queries and returns all relevant records (including demographic data, medical 
records, and accession numbers identifying medical images) for patients who match the specified 
search criteria (Query Items). It is a Microsoft SQL database sitting on a Windows server that can 
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be accessed from Partners workstations via the online query tool11 (see Figure 10 for an 
explanatory scheme of the query structure and process).  
 
 
Figure 10: Scheme of RPDR query12 
 
The first step consists of constructing a query that allows the user to select a population of 
interest without accessing any patient identifiers. Therefore this step does not require an IRB 
approved protocol but nonetheless, it requires being member of an RPDR registered Partners 
Faculty Sponsored Workgroup (Figure 10.1). At this level, only the aggregate number of patients 
who fit the selection criteria are available to the user. Other aggregate statistics such as gender, 
age, and ethnicity are also available.  
The second step is the patient information request. Since this includes personal information, it 
requires an IRB approved protocol in order to be launched. This can be requested either from step 
1 or from a pre-defined patient list. All patient information is then sent to the user in different text 
files in a pre-defined database format that can be handled by Microsoft Access software. 
Completing this step takes 1 to 3 weeks (Figure 10.2). 
 
The RPDR Query Tool web interface is shown in Figure 11. Any Query Items, such as encounter 
details, demographics (Age, Country, Gender, etc.), diagnosis or procedures, can be found in the 
left column of the page either by looking for the items of interest going through the folder 
hierarchy or by using the Find Terms tool provided that performs a keyword search. 
                                               
11http://www.partners.org/rescomputing/template.asp?pageid=99&ArticleTitle=RPDR&level1ID=9&tocID=9&articleSu
bPage=true 
12 Shawn Murphy MD, Ph.D., “Research Patient Data Registry (RPDR) at Partners Healthcare” presentation, January 31, 
2011 
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Figure 11: RPDR Enhanced Query Tool web interface 
 
When the desired item (criteria) is found, it is dragged to one of the columns that act like logical 
operators, either to the column where items are being linked by an OR operator or to the column 
linked by an AND operator as appropriate. Some other options are also available for each column 
such as Dates and Exclude. The former is used to restrict the dates at which the items in this 
column were performed and the latter excluding any patients who are related to the items 
included in this column (acting as an AND NOT logical operator). 
In this project, we wanted to obtain all the medical imaging data acquired at MGH since the 
year 2000 from any patients who had a brain MRI scan when they were 0 to 2 years old. In reality, I 
queried patients from 0 to 6 years old for the purpose of further investigation that will be done by 
others after I have completed this master project. The RPDR query tool has limited criteria and for 
example, there is no option to select the age of the patients at the time of the scan, but only their 
current age. Thus, to be certain not to miss any data, I selected a broader age range (0-17 years) in 
order to get at least all the data from 2000 of patients who could have been 0 to 6 years old at the 
time of the scan. From this, data from patients older than 6 years at the time of the scan were 
naturally acquired, but I was able to discard them during the next step (see part 3.2.2).  
For the first criterion, Age, the items from 0 to 17 years old were simply dragged to the first 
column. This indicated that all the patients whose ages were 0 or 1 or 2 or … or 17 years old were 
included in the search. 
The next criterion included only patients who had a brain MRI scan; this was not as 
straightforward as it appears. Indeed, this information has to be retrieved from the procedure 
description field of the records, which is not standardized and thus makes the criteria selection 
difficult. For example, MRI scan can be found under the following descriptions: “Brain imaging, 
complete study; static”, “Cerebral scan” or “Magnetic resonance (eg, proton) imaging, brain 
(including brain stem); with contrast agent” among others. Thus, any procedures which included 
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keywords related to brain MRI such as “MRI”, “Magnetic” or “Brain” using the Find Terms tool 
were manually selected and dragged to the second column (for the complete list of selected 
procedures items, see Appendix 8.4). For this criterion (column), the Dates option was used to 
restrain the query only to patients whose procedures were performed after 2000.  
In addition, we wanted to avoid patients with a history of human immunodeficiency virus (HIV), 
thus any patients with any diagnosis related to HIV were discarded (for the complete list of 
selected diagnosis items, see Appendix 8.5). Similarly, I found HIV related diagnosis using keywords 
and the Find Terms tool, dragged them to the third column and used the Exclude option this time 
to remove patients with HIV. 
Finally, MGH criterion was included in the fourth column to only retrieve patients imaged at 
MGH. 
In Boolean operators, the query criteria looked like this: “age from 0 to 17” AND “procedures 
field contain any term related to brain MRI” AND NOT “HIV diagnosis history” AND “MGH 
patients”. 
At this point, the query was run and the aggregate number of patients who met the selection 
criteria was displayed in the user interface as well as the other statistics (see results in part 4.1.1).  
The related identified patient data could then be requested (Figure 10, 2) and the query was 
reviewed to verify its compliance with the corresponding IRB approved protocol. If each step had 
been completed correctly, patient information was sent to the user.  
 
3.2.2. Microsoft Access Database queries 
 
From the RPDR query requested in the previous chapter (part 3.2.1), identified patient data 
were received in a pre-defined database format that can be handled by Microsoft Access software. 
It is a relational database (formatted for Microsoft Access) which is organized into different sets of 
tables, each containing a key or unique relationship that allows linking between tables.  
In this case, the database contained all the medical information (ranging from the dates of birth 
to physicians' hand written notes) concerning the patients. This information is organized into the 
following different tables: 
 
 the Demographics table contains the following fields for each patient: 
 
- EMPI (Enterprise Master Patient Index number): unique identifier for each patient across 
the different hospitals within Partners 
- MRN (Medical Record Number): unique identifiers for each patient within one particular 
hospital (e.g. within MGH) 
- MRN_Type: identifier of the institution associated with the MRN (e.g. MGH) 
- Gender 
- Date_Of_Birth 
- Age 
- Language 
- and other information related to demographic data (e.g. race, marital status, etc.) 
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 the Procedures table: 
 
- EMPI, MRN, MRN_Type 
- Date (of procedure) 
- Procedure_Name 
- Code_Type and Code: standardized system of charge codes for clinical procedures 
- Encounter_Number: unique identifier of the record/visit 
- and other information related to the procedure (e.g. the provider, the clinic, etc.) 
 
 the Encounter table: 
 
- EMPI, MRN, MRN_Type 
- Admit_Date 
- Encounter_Number 
- Principal_Diagnosis : condition established after study to be chiefly responsible for the 
admission of the patient to the hospital for care 
- and other information related to the visit/record (e.g. the physician making the diagnosis, 
etc.) 
 
 the Radiology table: 
 
- EMPI, MRN, MRN_Type 
- Report_Number 
- Report_Date_Time 
- Report_Text: containing information about the scan (written by the radiologist). It notably 
includes technical details and medical descriptions about the images as well as supposed 
diagnosis. 
- and other information related to the radiology visit/record. 
 
 Other tables containing additional information: for a complete list of all the tables available, 
see Appendix 8.6. (Details for each of these tables are available on the Partners RPDR 
website13)  
 
As listed above, all of the tables have several fields in common, thus allowing different tables to 
be linked in order to retrieve the information of interest. For example, if we are looking for the age 
of the patients at the time of their procedures: we need the date of birth of the patients (in 
Demographics table) and the date of the procedures (in Procedures table). By linking the two 
tables by their MRN and using a predefined function available in Microsoft Access software, we 
obtain the time elapsed between two dates, namely the date of birth and the date of the 
procedure. By performing such a query, we obtain a new table containing any fields we want from 
Demographics with any corresponding fields from Procedures for each patient. In Structured Query 
Language (SQL), this looks like the following expression: 
 
                                               
13 http://rpdrweb/partners/datainfo/datainfo.htm (only accessible through Partners network) 
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meaning that we want the query to return a table containing the following fields (cf. “SELECT”) for 
each patient: EMPI, MRN Type, MRN from Demographics (or from Procedures since they have 
these fields in common), the date of Birth from Demographics, the procedure date, name and the 
corresponding encounter number from Procedures, and the Age of the patient (cf. “AS Age”) at the 
time of the procedure using the function “DateDiff” which returns in months (“m”) the time 
elapsed between the two dates. The last line defines the link between the two tables: in that case, 
we link Demographics and Procedures by their common MRN field (“Demographics.MRN = 
Procedures.MRN”) with an “inner join” meaning that the resulting table will only include 
information (rows) where the joined fields (MRN in our case) from both tables are equal. 
The Microsoft Access software (also called “pseudo-relational database management system”) 
also allows us to filter the resulting table with certain criteria. We can for instance apply logical 
operators (=,>, <) in order to select patients in a specific age range at the time of their procedures. 
We can also use text operators such as “like” in order to filter data containing specific terms. 
Combining any of these methods together allows the construction of more complex queries 
satisfying all needs.  
 
In this project, I wanted to first determine and identify how many patients in each age range 
had a brain MRI scan (e.g. how many patients had a MRI scan when they were 12 months old) (see 
part 3.2.2.1) and then more specifically, how many of them had a diffusion MRI (3.2.2.2). The 
distribution of the scans according to the year in which they were completed was also investigated 
(3.2.2.3). Moreover, we were interested in the health history of the patients, namely whether they 
had been diagnosed as having any particular diseases. This is an important step since we only 
wanted to include patients with “normal” brain imaging data (i.e. no diagnosed brain abnormalities 
in their clinical reports) in the context of this project (3.2.2.4). In addition, longitudinal information 
about the patients was also investigated in order to know if a particular patient had had other MRI 
scans at a different age. This information could be very valuable for investigations about early brain 
development or time course of disease evolution (3.2.2.5).  Finally, I searched for brain MRI scans 
having corresponding Computed Tomography (CT) scans, since they could be potentially valuable 
for subsequent investigations (3.2.2.5). All the results related to these specific queries can be 
found in the results chapter (see part 4.1.2). 
 
3.2.2.1. Number of brain MRI scans for each age range 
Given the querying methods described above, I could start to complete the first query where I 
wanted to know how many patients from 0 to 6 years old (0 to 72 months old) had had a brain MRI 
scan for each age range (in months). The first step in this query was to determine the patients who 
underwent a brain MRI scan. As mentioned in part 3.2.1, the information “brain MRI scan” in the 
Procedure table can be found in different forms. When I completed the online RPDR query, I 
actually included 51 different types of procedures as inclusion criteria that could potentially 
“SELECT Demographics.EMPI, Demographics.MRN_Type, Demographics.MRN, 
Demographics.Date_Of_Birth, Procedures.Date, Procedures.Procedure_Name, Procedures.Code_Type, 
Procedures.Code, Procedures.Encounter_Number,  
DateDiff("m",Demographics.Date_Of_Birth,Procedures.Date) AS Age 
FROM Demographics INNER JOIN Procedures ON Demographics.MRN = Procedures.MRN;” 
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include brain MRI (see Appendix 8.4). Within the Access database, all these different procedures 
can be found under the Procedures_Name field of the Procedure table or under the corresponding 
Code field (see Appendix 8.4). After having explored the information related to these 51 
procedures in the database and under the direction of Dr. Ellen Grant, I refined the query to 12 
different procedures that are the most likely to include a brain MRI (see Table 1). 
 
Code Procedure_Name 
70552 Magnetic resonance (eg, proton) imaging, brain (including brain stem); with contrast material(s) 
70551 Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material 
70553 Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, 
followed by contrast material(s) and further sequences 
70542 Magnetic resonance (eg, proton) imaging, orbit, face, and neck; with contrast material(s) 
70540 Magnetic resonance (eg, proton) imaging, orbit, face, and neck; without contrast material(s) 
70543 Magnetic resonance (eg, proton) imaging, orbit, face, and neck; without contrast material(s), followed 
by contrast material(s) and further sequences 
70541 Magnetic resonance angiography, head and/or neck with or without contrast material(s) 
70545 Magnetic resonance angiography, head; with contrast material(s) 
70544 Magnetic resonance angiography, head; without contrast material(s) 
70546 Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) 
and further sequences 
88.91 Magnetic resonance imaging of brain and brain stem 
76390 Magnetic resonance spectroscopy 
Table 1: List of the 12 procedures that are the most likely to include brain MRI 
 
In order to obtain the age of the patients at the time of these procedures, I had to link the 
Demographics and Procedures tables by the MRN and include the “Datediff” function to display the 
age, adding two selection criteria, one for the age (>= 0 and <=72 months) and the other for 
procedures codes (i.e. only procedures containing one of the 12 codes listed just above were 
included).  
I realized afterward that the “Datediff” function didn’t return the age in months in the sense I 
understood it (“real age” of the patient according to the number of days between the date of birth 
and the date of the procedure). In fact this function simply calculates the difference between the 
month of birth and the month of procedure meaning that a person who was born on 11/01/2000 
and had an MRI scan on 12/31/2000 (so aged 12-11 = 1 month) would have been the same age at 
someone who was born on 11/30/2000 and had an MRI scan on 12/01/2000 even though the 
former was 60 days old and the later 1 day old and thus didn’t have the same “real age” in months. 
To avoid any further source of confusion, I always used ages in days and consider age in months 
according the time elapse in days (0 month old being aged from 0 to 29 days, 1 month old from 30 
to 60 days, 2 months old from 61 to 90 days and so on); the age in days can be retrieved from 
Microsoft Access using the same “Datediff” function but replacing the “m” (month) option by the 
“d” (day) option. 
 
3.2.2.2. Proportion of MRIs that include diffusion imaging 
The next step was to refine the query by specifying the proportion of these scans supposedly 
containing diffusion MRI data. Two major difficulties emerged: first, no specific fields in Procedures 
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mentioned whether the procedures include diffusion data. This information has to be retrieved 
from the Radiology table under the Report_Text field stated in a non-standardized manner by 
physicians. As a result, I had to filter the radiology reports not according to standardized codes, but 
according to keywords such as “diffusion”, “DWI”, “ADC”, “DTI” or “diffusivity”. In other words, the 
patients whose Report_Text fields contained at least one of the previous diffusion-related terms 
were included. The second problem was that the Report_Text fields from Radiology could not be 
directly linked to their corresponding procedures by a common encounter number for instance. I 
had to link them indirectly according to their dates: for each patient brain MRI scan (procedure) 
found in the previous query, I looked for a corresponding Radiology_Text written within 2 days of 
the procedure for the same patient 
 
3.2.2.3. How old are the scans? 
 A specific query was also constructed in order to know the distribution of the brain MRI scans 
according to the date (in years) when the scans were executed. This information was useful when 
selecting the most interesting scans for the project because the quality and validity of our results 
partly depended on their similarities in term of modalities and MRI sequence parameters. Hence, 
the closer in time the scans were run, the more likely they would be “technically” comparable. 
 
3.2.2.4. “Normal” or “Abnormal” brain MRI scan? 
The next step was to investigate more precisely the health history of the patients and their 
related diagnoses. The purpose of this step was to identify patients whose brain MRI scan seemed 
to be “normal” (i.e. without apparent major abnormalities in their brain images). This information 
can be retrieved, at least partially, under two different fields: Report_Text field in Radiology and 
Principal_Diagnosis field in Encounter. Report_text fields notably contain written reports of MRI 
data where physicians assess health states of patients describing their brain images. Let’s have a 
look at the following Report_text taken from a patient (exam number, Date/Time and names had 
been removed for confidentiality reasons): 
 
Exam Number:                               Report Status:  Final 
Type:  MRI BRAIN - 
Date/Time: 
Exam Code:  MRBRN/SED 
Ordering Provider: 
 
HISTORY: 
eval for structural abnormality 
PEDI SEIZURE PROTOCOL, SUSCEPTIBILITY.  JH.... 
 
DIAGNOSIS: 
new onset seizures 
 
REPORT: 
This study was reviewed with Dr. X 
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History of seizure like episodes with clenching of teeth and crossing legs. 
Brain MRI without gadolinium enhancement according to pediatric seizure protocol and 
susceptibility axial images. There are no prior studies available for comparison. 
There is no evidence of abnormal susceptibility artifact suggest blood products or calcification. 
The brain is normal in signal intensity and morphology. There is no evidence of cortical dysplasia 
or gray matter heterotopia. 
There is no evidence of an infarct by diffusion weighted imaging. 
There is no evidence of intracranial hemorrhage. The size of the sulci, ventricles, and cisterns are 
age appropriate. There is no extra-axial fluid collections. The visualized soft tissues are 
unremarkable. The globes are unremarkable. There is mild mucosal thickening within the 
maxillary sinuses. 
 
IMPRESSION 
Unremarkable brain MRI with no identifiable structural abnormality.. 
 
RADIOLOGISTS:                           SIGNATURES: 
 
 
Even though this patient was admitted for a “new onset seizures” diagnosis, his overall brain 
imaging data seem to be normal, and thus could be included as a “normal” subject in our cohort 
study. Let’s take another example: 
 
Exam Number:                                 Report Status:  Final 
Type:  MRI,Brain W/O 
Date/Time:   
Exam Code:  580/NE 
Ordering Provider:   
 
HISTORY:   
     33 WK PREEMIE WITH GRADE 4 IVH, DEPRESSED NEUROLOGICAL STATUS 
ALSO INTUBATED. 
 
REPORT: 
This examination was reviewed with Dr. X 
An MRI of the brain was performed including sagittal T1 weighted images, axial T1, FLAIR, T2 
and diffusion weighted images. 
Comparison is to the CT scan dated ... 
There is evidence for a left germinal matrix hematoma that has ruptured into the left ventricle. The 
ventricles are massively dilated and filled with hemorrhage, left greater than right with blood/fluid 
levels. There is parenchymal extension of the hemorrhage through the corpus callosum into the 
left cingulated gyrus and the left centrum semiovale. The parenchymal hemorrhagic extension 
extends to involve the posterior left thalamus.  These findings are not significantly changed from 
the CT scan. 
There is evidence for subarachnoid hemorrhage in the sulci of the right frontal and parietal lobes 
which may represent recirculation of the subarachnoid hemorrhage present in the ventricles. 
There is extensive T2 white matter hyperintensity present, much of which may be due to 
immaturity. However, there is more intense signal in the parietal lobes bilaterally which may 
represent superimposed edema. 
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There are several foci of hyperintensity on the diffusion weighted images in the medial parietal 
lobes bilaterally. However, there is no ADC restriction in this location and acute infarction is 
unlikely. 
There is low T2 signal in the thalami bilaterally and posterior lentiform nuclei bilaterally as well 
as the posterior pons along the floor of the fourth ventricle. These areas may represent petechial 
hemorrhage versus myelin breakdown products. 
 
IMPRESSION 
1. EVIDENCE OF A LARGE LEFT GERMINAL MATRIX HEMORRHAGE WITH RUPTURE 
INTO MASSIVELY DILATED LATERAL VENTRICLES AND PARENCHYMAL 
EXTENSION AS DESCRIBED ABOVE. THIS APPEARANCE IS NOT SIGNIFICANTLY 
CHANGED FROM THE PRIOR CT SCAN. 
2. THERE IS LOW T2 SIGNAL IN THE THALAMI BILATERALLY AND POSTERIOR 
LENTIFORM NUCLEI BILATERALLY AS WELL AS THE POSTERIOR PONS ALONG THE 
FLOOR OF THE FOURTH VENTRICLE. THESE AREAS MAY REPRESENT PETECHIAL 
HEMORRHAGE VERSUS MYELIN BREAKDOWN PRODUCTS. 
3.  THERE IS EXTENSIVE T2 WHITE MATTER HYPERINTENSITY PRESENT, MUCH OF 
WHICH MAY BE DUE TO IMMATURITY. HOWEVER, THERE IS MORE INTENSE 
SIGNAL IN THE PARIETAL LOBES BILATERALLY WHICH MAY REPRESENT 
SUPERIMPOSED EDEMA. 
 
RADIOLOGISTS:                           SIGNATURES: 
 [report_end]  
 
In this case, it is obvious that the patient suffers from major abnormalities affecting the integrity of 
the brain and thus such a patient had to be discarded from the “normal” patient cohort.  
This information can only be retrieved by individually reading through each report, 
consequently, the prospect of building an automated method/query that could filter patients 
according to their status (“normal” versus ”abnormal”) was not feasible. Nonetheless, one part of 
the radiology reports shared by all is worthy of special attention, namely the “IMPRESSION” 
section. Indeed, it contains a final note summarizing the reports that can facilitate the evaluation 
of the patient’s status and optimize the time needed to read through hundreds or even thousands 
of reports. After spending dozens of hours reading through hundreds of radiology reports, I quickly 
realized that key sentences were used by different radiologists to describe a brain as “normal” in 
this section; I recorded them and a non-exhaustive list is available in Appendix 8.7. This list could 
be used towards the goal of developing automated ways of selecting patients of interest for 
further investigations using for example machine learning methods with the complete list of key 
sentences as training data (see Discussion part 5.1). 
We have to keep in mind that radiology reports are not always as easily classified as the two 
examples provided above, their interpretation could be subject to personal judgments that would 
render their automated classification even more challenging. Practically speaking, when such an 
ambiguous case was encountered (i.e. when a radiology report could not be unequivocally 
classified as “normal” or “abnormal”, according to my current medical knowledge), the patient was 
classified as “undefined” and set aside for further investigations by more knowledgeable people in 
the field in order to be correctly classified.  
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In order to keep track of this classification, I created another table in the Access database which 
contained two fields: MRN and Status. After each radiology report was reviewed, the 
corresponding patient was tagged as “Normal”, ”Abnormal” or “Undefined” in this table. This new 
table could be linked to the other ones and used as explained in previous chapters in order to 
refine the queries. Therefore this table enabled the selection of patients not only according to their 
ages or procedures but also according to their brain image health status. 
 
3.2.2.5. Longitudinal data 
The last part of this database mining was to investigate the availability of longitudinal brain MRI 
datasets. In other words, I wanted to know whether some patients had multiple brain MRI scans at 
different ages. Basically, the same protocol explained in part 3.2.2.1 was used in order to obtain 
the ages at which they had a scan for each patient. The resulting table displayed a list of MRNs (i.e. 
a patients’ list) with the corresponding ages at the time of scan (2 column table). In order to 
present these results in a more intuitive way, I wrote a small script in Visual Basic (VB) 
programming language to first transform this two-column table into a more comprehensive one 
and then include additional information. 
 
3.2.3. MRI data retrieval from PACS – mi2b2 software 
 
The last chapters were dedicated to the search of patients of interest by using different 
appropriate selection criteria. Once the patient cohort and the related MRI procedures had been 
determined, the corresponding data needed to be retrieved out of MGH PACS. 
 
3.2.3.1. PACS 
In the medical field, PACS, as its name suggests, is a system that provides hospitals with short 
and long term digital storage, rapid retrieval, management, within and between site distribution 
and presentation of images of various modalities including Ultrasound (US), Computed 
Tomography (CT), Positron Emission Tomography (PET) and MRI, among others. It was first 
developed to replace hard copies such as film archives or hard copy reports by digital supports, 
saving, as a result, a considerable amount of space, money and greatly facilitating its use. Beside its 
archive storage utility it also provides a secured network for the transmission of patient 
information as well as workstations for viewing, processing and interpreting images (Huang, 2011). 
This system gave us access to the medical data stored in Digital Imaging and Communications in 
Medicine (DICOM) format, which is the universal format used in PACS image storage and transfer. 
A DICOM file not only contains images (pixel data), but also other information such as patient 
identifiers, demographics, and technical information regarding the scanning sequence parameters 
As researchers, we don’t have direct access to this system which is a real gold mine in terms of 
the quality and amount of medical data it contains. This is the reason why the Medical Imaging 
informatics Bench to Bedside (mi2b2) team has put all its efforts into facilitating access to PACS 
and promoting translational investigations. 
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3.2.3.2. mi2b2 software 
As briefly described in the introduction, the mi2b2 project is being developed and deployed by a 
dedicated team with the aim of providing the infrastructure and regulatory policies necessary to 
locate and retrieve medical images from PACS14. I had the chance to be the first external user 
working with a prototype of this software. As such, I was able to provide the mi2b2 team with 
feedback either by directly using the software and reporting errors due to faults or missing 
elements in the programming and by giving comments about the user interface and functionalities.  
Technically speaking, the mi2b2 software provides a way to obtain images from a clinical PACS, 
but it does so in a way that enables research use of the image data stored in the PACS.  Although 
many research-oriented viewing workstations (OSIRIX15) can connect to a PACS, the clinical 
Radiology departments need assurance that retrieving images for research will not interfere with 
the clinical mission.  In a typical research project, many thousands of images may be obtained, and 
often in usage patterns that are quite different from conventional clinical workflow (research 
requests for images often delve deep into imaging archives).  Furthermore, audit logs for clinical 
PACS that must comply with Health Insurance Portability and Accountability Act (HIPAA)16 and IRB 
regulations that need to be followed when obtaining images for research are not easily 
accessible.17 
 The graphical user interface of the mi2b2 Workbench shown in Figure 12 is designed for 
automating and streamlining the process of retrieving images from the clinical PACS for research 
purposes (Murphy, Marcus et al, 2011)18.  The Workbench is a Java Eclipse plug-in that leverages 
the existing i2b2 open source framework (see Introduction) to communicate through RESTful web 
services with a corresponding mi2b2 server-side web application. The mi2b2 server-side cell is also 
built with Java and the i2b2 framework, but additionally utilizes the dcm4che toolkit19 to find and 
move DICOM images from the clinical PACS and store them in a local cache. The resulting workflow 
is designed to preserve clinical performance of the PACS while efficiently retrieving only the 
desired medical images in a secure way.   
Briefly described, the interactive steps are as follows.  Once the set of patients has been 
determined (see parts 3.2.1 and 3.2.2), the list of MRNs is submitted to the mi2b2 Workbench to 
retrieve information on which imaging studies exist for each patient.  In the future, queries can 
also be made with the accession numbers that are specific to the particular imaging study20.  
Unfortunately, we could not use accession numbers for this project because they were not yet 
included in the Procedures table we obtained from RPDR. This feature has only been added in the 
past two months. Mi2b2 queries the PACS and returns the complete list of available studies for 
each patient. We then browse through the list and select the imaging studies to be downloaded. 
Because there may be hundreds of studies returned, only a subset of which are our target images, 
                                               
14 See mi2b2 wiki page: http://www.na-mic.org/Wiki/index.php/CTSC:ARRA_supplement 
15 http://www.osirix-viewer.com/, ClearCanvas, http://www.clearcanvas.ca/dnn/ 
16 http://www.cms.gov/HIPAAGenInfo/02_TheHIPAALawandRelated%20Information.asp#TopOfPage 
17 Adapted from the RO1 grant application (see end of the introduction) 
18 Murphy SN, Marcus D, et al. New Tools for Integrating Clinical Images into Research Studies. Presented at Society for 
Imaging Informatics in Medicine. 2011. 
19 http://www.dcm4che.org/ 
20 A study, in this context, is defined as one data set for one particular patient at a specific scanning visit; the term 
series is applied for on particular sequence (T1-, T2-weighted images, DWI images, FLAIR images, etc.) within one 
study. 
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one or more filtering and sorting criteria can be used to quickly refine the search list to include only 
those target images.  Once a final study list has been determined, this list is submitted to mi2b2 for 
download along with the location of a directory where the images should be copied (Figure 12, 
upper image). 
 
 
Figure 12: Mi2b2 workbench user interface. It queries the PACS for selected MRNs and returns the complete list of 
available studies for each patient. One or more filtering and sorting criteria can be used to quickly refine the search 
list (upper image). An additional tab (which was not available in the prototype I used) will be used to view image 
files directly from the mi2b2 cache before transferring them to the users own disk space (lower image)21. 
 
  
                                               
21 Adapted from Gollub RL, Roch V et al.. Developmental brain ADC atlas creation from clinical images. Displayed at the 
Organization for Human Brain Mapping, Canada, June 2011. 
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 The mi2b2 server will then queue these requests and download the images based on the rules 
governing the interaction with each individual institutions’ PACS. The rules limit the time, rate, and 
number of images that may be downloaded in parallel.  They are set for each institution so as to 
not interfere with the clinical workflow.  Users can use the mi2b2 Workbench to check the status 
of their image downloads at any time. Once mi2b2 downloads the images, the status of the 
request is updated and the user can find their images in their specified directory location. Users 
also have the ability to use the mi2b2 Workbench to view the image files directly from the mi2b2 
cache before they are transferred22 (Figure 12, lower panel).  
In the prototype version that I used, the viewing tab was not yet available and images requested 
were first downloaded to mi2b2 team members’ workstation (Bill Wand, Chris Herrick and David 
Wang, see People Section 8.3) and then to a secured Windows Share I had access to through my 
secure Partners logon. The Production version of the software will be released to the Partners user 
community in the Fall of 2011. 
 
3.2.4. Automated MRI data organization: the “BB-pipeline” 
 
When patient studies are retrieved from PACS through the mi2b2 software, they come in a 
format that is not well designed for dealing with a huge amount of imaging data (more than 30,000 
different volumes retrieved). I built the BB-pipeline for use in a Bash shell on my Linux workstation 
with the following guidelines in mind: reducing to a minimum any manual steps and facilitating as 
much as possible further data findings. This pipeline had been improved as I was progressing with 
this project to fit the special needs and the increasing number of data sets retrieved from PACS 
through the development of the mi2b2 workbench. Not all studies were requested and retrieved 
from PACS at once; rather they had been progressively pulled out since February 2011. The aims of 
this pipeline were to 1) transform “poor” directory hierarchy and name formats into a categorized 
hierarchy with meaningful name formats, 2) convert DICOM images into NIfTI23 format, 3) extract 
technical information about scans to add to the Access database, and 4) to keep track of any 
studies requested and received from PACS. 
 
Figure 13 delineates the steps required to achieve these aims. Here is a description of the 
automated BB-pipeline through which all the data sets were sent after PACS retrieval: 
 
(1)  
All retrieved studies are transferred from the shared space (see part 3.2.3.2) to our local 
workstation and decompressed (“unzipped”) (Studies are compressed by mi2b2 software when 
retrieved from PACS). 
 
                                               
22 Adapted from the RO1 grant application (see end of the introduction) 
23 See Neuroimaging Informatics Technology Initiative web site: http://nifti.nimh.nih.gov/nifti-1/ 
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Figure 13: BB-pipline workflow. Data received from PACS are first transferred and decompressed to the local 
workstation (1). They are then sent through Rudolph’s pipeline and age calculator that rename and pre-organize the 
raw data (2)-(3). Using Access information input, the studies are then sorted into different directories according to 
their age and health status (4). DICOM files are converted into NIfTI fomat and sent to the working directory (5). 
DICOM headers are extracted and added to the Access database (6), and log file is updated (7). 
 
 
(2)  
Data are then automatically sent through a pipeline (which has been developed by Rudolph 
Pienaar, see People section 8.3) that renames and pre-organizes the data.  
This system is essentially a DICOM listener/unpacker that receives DICOM user SCU/SCP (Service 
Class User / Service Class Provider)24 requests/services. It is built off a DICOM toolkit (DCMTK) set 
of applications25. Upon receipt of DICOM data, several other scripts parse the incoming data for 
information such as MRNs, age, scan time, machine type and machine ID from the DICOM headers. 
All images are packed into a directory with a name based on these tags (i.e.  <MRN>-<AGE>-
<SCANTIME>.... etc.). Images are renamed according to their series numbers which correspond to 
particular series types (T1-, T2-weighted images, DWI images, FLAIR images, etc.). 
Once the final transmission has been received, a termination script analyzes all the received 
images and builds a table-of-contents text file that is stored in the directory. This file can be quickly 
consulted in order to get an idea of what the study contains: 
 
                                               
24 For further additional information, see Oleg S. Pianykh (2008), Digital Imaging and Communications in Medicine 
(DICOM) : A Practical Introduction and Survival Guide, Springer-Verlag (Berlin Heidelberg)  
25 http://dicom.offis.de/dcmtk.php.en 
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                          Patient ID        7928364 
                        Patient Name        TART^EMPION 
                         Patient Age        002Y 
                         Patient Sex        M 
                    Patient Birthday        20030901 
                     Image Scan-Date        20050931 
                Scanner Manufacturer        GE MEDICAL SYSTEMS 
                       Scanner Model        GENESIS_SIGNA 
                        Software Ver        08 
 
            Scan 0-000001-000001.dcm        SAG T1 
            Scan 0-000003-000001.dcm        AX FLAIR 
            Scan 0-000004-000001.dcm        AX T2 FSE 
            Scan 0-000005-000001.dcm        AX SPGR 3D 
            Scan 0-000006-000001.dcm        COR FSE T2 
            Scan 0-000007-000001.dcm        SAG FSE T2 
            Scan 0-000100-000001.dcm        DWI 
            Scan 0-000101-000001.dcm        ADC 
            Scan 0-000102-000001.dcm        LOWB 
            Scan 0-000103-000001.dcm        EXP 
            Scan 0-000104-000001.dcm        FA 
 
(3)  
Once the study has passed through Rudolph Pienaar’s (See People Section 8.3) system, the BB-
pipeline further modifies the directory name format because the <AGE> fields extracted from 
DICOM headers are not in a suitable format for further automated age-specific analysis. Indeed, 
patient ages are displayed in days, weeks, months or years depending on their age range. In 
consequence, I wrote a script that renames each study directory with a unified age format (in days) 
by extracting the date of birth and the procedure date of each patient study from the DICOM 
header, and calculating the time elapse between these two dates. 
At this point, we have transformed inconvenient name formats (see Figure 14) into meaningful 
ones that are easy to handle (see Figure 15, Studies and Images). 
 
(4)  
This step consists of sorting the data according to the age of the patients and their health status 
(see part 3.2.2.4). To do so, information from the Access database has to be accessible to obtain 
the health status of the patient. Since the Access software is not available from the workstation 
and is not convenient to work with in terms of compatibility when using Bash scripts, a manual 
step is needed to retrieve individual patient health status and send it as input for the BB-pipeline. 
Basically, this information is exported from the Access database to a two column text file 
containing the list of MRNs with the corresponding health status. This text file has to be sent 
manually to the workstation in a dedicated directory to which the BB-pipeline has access. 
From here, the pipeline reads through the text file and sorts the data accordingly (Figure 15, 
Health status). The data that are retrieved from PACS but are not yet classified are sent to a 
temporary directory. Simultaneously, a function calculates the age of the patient in months from 
the age in days and sorts the studies accordingly (Figure 15, Age, Health status). 
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Raw data
directory
2.4.421.332467.432.672.12.98.20010609.624261.67732115
...
2.4.421.332467.432.672.12.98.20051005.378581.12371993
2.4.421.332467.432.672.12.98.20030303.039836.27648193
2.5.32.3.2265.6.3.76.12456.2010041084716491010934756.0.0.0
2.5.32.3.2265.6.3.76.12456.2010041088457163571358718.0.0.0
...
2.4.421.332467.432.672.12.98.20101112.378581.12371993
2.4.950.224743.3.6.2453453355.2634.2042385726.243.dcm
2.4.950.224743.3.6.2453453355.2634.2042385726.244.dcm
...
2.4.950.224743.3.6.2453453355.2634.2042385726.387.dcm
Studies
Series
Images
 
 
Figure 14: Directory hierarchy and name format as retrieved from PACS. Directory and file names are a combination 
of institution, manufacturer, machine model, and randomly generated numbers based on date and time. According 
to DICOM, they are globally unique identifiers.  
 
 
 
Organized data
directory
0 month
1 month
...
24 months
Abnormal
Temporary
Undefined
4572840-744-GENESIS_SIGNA-0000000573573mr3-20011009-047657-000000
5670929-752-GENESIS_SIGNA-000000084814mr3-20030204-758292-000000
...
7928364-760-GENESIS_SIGNA-000000000-20050931-085636-000000
Age
Health status
Studies
0-000101-000001.dcm
0-000101-000002.dcm
...
0-000101-0000023.dcm
Images
Normal
 
 
Figure 15: Directory hierarchy after data have been sent through BB-pipeline. They are now sorted according to the 
age in months, health status, names of directories, and files have been transformed meaningfully: the study name 
now contains patient MRN, age in days, study date, and other scanner information. The image name includes the 
series numbers corresponding to a particular series type (T1-, T2-weighted images, DWI images, FLAIR images, etc.). 
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(5)  
After the names and structure of the results have been transformed, DICOM images (.dcm) that 
are needed for further data analysis are converted into NIfTI format (.nii) which is easier and faster 
to work with. Indeed, each whole volume in DICOM format is separated in several files, one for 
each slice. For instance, an ADC volume is found as: 
 
0-000101-000001.dcm 
0-000101-000002.dcm 
0-000101-000003.dcm 
… 
 0-000101-0000023.dcm 
 
101 being the series number corresponding to ADC images and 1, 2, 3, …, 23 corresponding to the 
slices. Furthermore, as mentioned earlier, DICOM files contain a lot of additional information about 
patients and scan parameters that are not directly needed when working with the images only. 
This excess information also slows the process. Thus, converting DICOM images into NIfTI format 
stacks separate slices into one single file and eliminates patient information, resulting in only the 
useful information regarding the scan volume (orientation, number of slices, pixel dimensions, 
etc.). 
The pipeline automatically passes through all the DICOM files, looks into the corresponding 
headers (“series description”) for key words related to the series we are interested in (DWI, ADC, 
FA, LOWB, AX-T2 for instance), converts images into NIfTI file with the following name format 
convenient to work with: 
 
<MRN> - <Age> - <Scan_Date> - <Series_Number> - <Series_Name> 
 
and finally sorts the data according to the same steps as explained in (4). All the DICOM files are 
kept intact in a storage directory. 
 
(6)  
This step consists of extracting additional technical information about retrieved scans and 
including them in the Access database. By doing so, the completed database not only contains all 
the information about patient procedures, radiology reports, and diagnosis, but also all the related 
technical scan details that will be used to select the data of interest (see part 3.2.5). 
The pipeline goes through all the series and extracts any chosen related DICOM headers. The 
extracted information contains mainly details about scan sequences such as TR, TE or the name of 
the series (T1-, T2-weighted, ADC, FA, …), but also some information about the resolution of the 
images (see Appendix 8.8). All these DICOM headers are extracted from each series to a text file (in 
a specific format) that is manually included as a new table in the Access database (now called 
“enhanced Access database”). 
 
(7)  
Finally, a text file, containing the list of MRNs and the corresponding scan date of each study 
that has been sent through the pipeline, is generated and used to update an excel sheet log file. 
This log file contains, for each study, the MRN and corresponding study date as well as the date it 
was requested from PACS through mi2b2. A VB script takes the previously generated file and 
updates the log file with retrieval dates (see Table 2).  
  
  Materials and methods 
   
- 33 - 
MRN Study Date Request # Request Date Status Retrieval Date Age in days >= 2scans
4357692 3/7/2002 6 3/9/2011 done 3/15/2011 65
4568929 4/21/2003 12 4/5/2011 done 4/11/2011 171
4798324 4/7/2003 7 3/15/2011 done 3/18/2011 79 x
4798324 4/17/2003 7 3/15/2011 done 3/18/2011 89 x
5678989 5/3/2004 12 4/5/2011 pending 599
5839587 2/23/2005 5 3/7/2011 done 3/8/2011 185 x
6738598 11/14/2005 11 3/28/2011 done 4/8/2011 449 x
6738598 6/29/2009 11 3/28/2011 pending 1072 x
6937563 1/5/2006 10 3/21/2011 done 3/28/2011 15
7984745 7/21/2006 25 5/13/2011 pending 872
8364634 3/1/2007 10 3/21/2011 done 3/28/2011 9 x
8573645 2/2/2007 10 3/21/2011 done 3/28/2011 12 x
… … … … … … … …
8736545 1/26/2007 10 3/21/2011 done 3/28/2011 34
8936745 1/27/2007 19 4/29/2011 done 4/30/2011 3
9164653 2/27/2008 19 4/29/2011 not found 2
9465257 1/23/2008 12 4/5/2011 done 4/14/2011 218
9672356 1/17/2009 19 4/29/2011 done 4/30/2011 10 x
9672356 1/22/2009 19 4/29/2011 done 4/30/2011 15 x
9672356 1/23/2009 19 4/29/2011 done 5/3/2011 16 x
9832545 2/11/2010 12 4/5/2011 done 4/14/2011 491  
Table 2: The log file contains MRNs with their corresponding study date, request number (equivalent to a request 
ID) with its request date, the status of the request, the date at which the study has been retrieved and finally other 
useful information concerning the study (Age in days and whether the patient has had several scans). The study is 
flagged as “done”, “pending” and “not found” depending on whether the study has been successfully retrieved, not 
yet retrieved or was not found in the PACS respectively. A VB script automatically updates this datasheet from the 
text file generated by the BB-pipeline. 
 
This log file was useful in working with the development mi2b2 prototype in order to give feedback 
to the mi2b2 team regarding the number of PACS requested studies and the number actually 
retrieved, and to re-request only the data that were not retrieved. It was also helpful when 
requesting new data that had not been already requested in previous queries.  
 
Finally, another script was used to automatically update the DICOM storage directory and the 
NIfTI working directory after the Access database was modified in terms of health status in order to 
sort the studies sitting in the temporary directories (see step (4)) or to redirect studies whose 
health status had been modified. 
 
3.2.5. Selecting data of interest 
 
At this stage, all the information (medical information and technical scan parameters) 
concerning retrieved studies was available in the enhanced Access database allowing, as a result, 
the execution of the previously mentioned request example (see part 3.2, end of the overview): 
 
“Give me the ADC volume of any patients who were scanned at the age of 30 to 60 days whose 
corresponding radiology reports don’t mention any major brain abnormality” 
 
It was necessary to link the new “technical” table with the Demographics table to calculate the 
age in days of the patient at the time of the scans using an age restriction (>= 30 and <= 60) and a 
criteria for the sequence name (Like “ADC”), and finally include a criteria on the “status flag” table 
  
  Materials and methods 
   
- 34 - 
to only query “normal” patients (namely those whose radiology reports mentioned no major 
abnormality). Querying any combination of Access tables for specific criteria, at that point, allowed 
the retrieval of any information of interest and an easy access to the corresponding sorted images 
either in the DICOM storage directory or the corresponding NIfTI working directory. 
 
With the framework in place to be able to selectively and repeatedly access images that fulfill 
specific criteria, the next challenge was to determine whether the image acquisition parameters of 
these scans were sufficiently comparable to enable directly pooled analyses. 
When working with diffusion images, the first image acquisition parameter that has to be taken 
into account is the b-value as explained in part 2.1. In theory, D values are understood to be an 
intrinsic property of the brain for a determined volume, but the reliability of the D values partially 
depends on b-values specified by the diffusion scan sequences (Ogura et al., 2011). TE, TR as well 
as other parameters have less of an influence on D values, but rather these specifications affect the 
quality of the images, Signal to Noise Ratio (SNR), and accuracy of measured D values26. 
Another concern that was raised by reviewing the retrieved data that was collected between 
2000 and 2010 and confirmed by Dr. Ellen Grant, was the complete change in the pediatric 
acquisition protocol for MR diffusion imaging sequences at MGH between the years 2005 and 
2006. At that time, under her supervision they completely changed the software and the sequence 
parameters used for diffusion MRI in order to improve the resolution and the quality of the images. 
Unfortunately, we noticed that a lot of diffusion volumes acquired using the new protocol (2006-
2010) contained artifacts and were less consistent across patients. Dr. Ellen Grant confirmed that 
clinicians had encountered some difficulties with the new protocol which directly affected the 
diffusion scans. For these reasons, and for the limited amount of time that I had at my disposal to 
analyze the data, we decided to focus further investigation using only the images with the “old” 
sequence parameters (before the year 2006) when the diffusion scans were more consistent in 
terms of the quality and sequence parameters across patients. This insured a higher comparability 
across different patients at the cost of lower resolution and less accurate diffusion indices.   Future 
work of the team will focus on developing image processing and/or statistical modeling approaches 
to enable use of the newer data for the analyses done for this thesis. 
All the details concerning the choices of diffusion data can be found in the results section part 
4.1.4. 
 
3.3. MRI Data Analysis 
 
This last method section is dedicated to MRI data analysis per se, using the data that were 
retrieved and met all the selection criteria described in the previous chapters. Despite filtering out 
a considerable number of patients, I still ended up with several hundred studies that could be used 
for data analysis. Taking into account the limited amount of time left at this point, any manual 
processing (e.g. ROI delineation) or new algorithm development was not feasible. Consequently, 
                                               
26 Adapted from a discussion with Simon K. Warfield, Ph.D., Professor of Radiology, Harvard Medical School, Director of 
Radiology Research, Director Computational Radiology Laboratory, Department of Radiology, Children's Hospital 
Boston. 
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we decided to investigate time evolution of diffusion indices across ages using already available 
tools and simple processing methods that can be automated as much as possible.  
We focused our attention on two diffusion indices, namely ADC and FA. In brief, for each 
selected volume we removed any non-brain parenchyma regions and calculated the average ADC 
and FA values for the whole brain. This gave two values (two markers: whole brain ADC and FA 
average) for each volume which was compared across patients at different time points (for sake of 
simplicity, these two markers were called WBAADC and WBAFA values, WBA = Whole Brain Average) 
 
3.3.1. Average calculation of whole brain diffusion indices 
 
I specifically developed this brain extraction pipeline for the sake of this project (with advice 
from Dr. Ellen Grant, Lilla Zollei and Rudolph Pienaar), trying to find the best methods that did not 
require any manual editing of images. Several attempts were necessary to reach this goal and this 
process gave me my first insight in brain imaging tools use and script designs. This pipeline is 
displayed in Figure 16. 
The first processing step to remove non-brain regions is a brain extraction procedure carried out 
by the Brain Extraction Tool (BET)27 as part of the FMRIB Software Library (FSL)28.  This method is 
based on a deformable model which evolves to fit the surface of the brain by applying a set of 
locally adaptive model forces (Smith, 2002). It finds the surface of the brain (including brain stem 
and cerebellum) and removes external non-brain regions. I tried to use BET directly on ADC or FA 
volumes but since this tool was initially developed to be used on T1- or T2-weighted volumes, it did 
not work properly. Hence, for each ADC/FA volume I used the corresponding LOWB volume 
(reference volume, which is actually a T2-weighted volume) in order to effectively run BET (Figure 
16, (1)).  
The default parameters were used except for the Fractional Intensity Threshold (FIT)29 that was 
set at 0.4. After testing different FIT values, we determined that this value worked the best on the 
LOWB volumes. Using the output of BET from the LOWB volumes, a mask was generated and 
applied to the corresponding ADC volumes (Figure 16, (2)). 
BET does not remove Cerebrospinal Fluid (CSF).   CSF needs to be excluded from the ADC and FA 
average calculations. CSF is not brain tissue, varies in size widely across individuals, and has 
markedly higher ADC and lower FA values thus introducing a spurious confound into WBAADC and 
WBAFA measures. Therefore, a different way to remove CSF had to be found. Water molecules in 
CSF are known to have a nearly free diffusion property and thus should appear as voxels with 
highest value in ADC volumes (which represent the average water diffusion rate for each voxel, see 
part 2.1). As a result, a voxel-wise upper threshold (threshold = 2.05 x 10-3 [s/mm2]) was applied on 
previously brain extracted ADC volumes in order to get rid of CSF regions (Figure 16, (3)). Several 
threshold values were tested and the resulting volumes were visually inspected in order to find the 
best threshold value.  
 
                                               
27 http://www.fmrib.ox.ac.uk/fsl/bet2/index.html 
28 http://www.fmrib.ox.ac.uk/fsl/ 
29 The default FIT is 0.5, by setting it under 0.5, the overall segmented brain becomes larger (<0.5) and is less 
restrictive. 
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Figure 16: Data processing workflow for the calculation of WBA ADC and FA. The LOWB volume is brain extracted 
through BET (1) and applied as a mask to the ADC volume (2). Then, an up-threshold is applied to this volume in 
order to remove CSF regions (3) and the resulting ADC volume is sent through BET (4) to obtain the fully processed 
ADC volume. At the same time, a mask is generated (5) and applied to the corresponding FA volume (6) to obtain 
the fully processed FA volume. 
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By visually inspecting the outputs of this last processing step, I noticed that some non-brain 
tissue remained at the periphery of the brain (e.g. fragments of skull, dura, etc). I found that 
applying BET (FIT = 0.4) directly on these ADC volumes was effective in removing these remaining 
non-brain regions at the periphery without affecting any other parts of the brain (Figure 16, (4)). In 
this way, the fully processed ADC volumes were obtained and used for average calculations. 
The non-zero voxels in these newly obtained ADC volumes for each individual were then used as 
a mask (Figure 16, (5)) for their corresponding FA volumes (Figure 16, (6)). Thus, fully processed FA 
volumes used for average calculations were obtained. 
Finally, whole brain averages were calculated from non-zero voxels of fully processed ADC and 
FA volumes (Figure 16, (7)) using MatLab (The MathWorks, Natick, MA, USA). 
 
3.3.2. Diffusion indices time evolution analysis 
 
The final aim of this project was to use the previously calculated WBAADC and WBAFA values in 
order to investigate the time evolution of these markers across ages. 
I first looked at the effect of the data processing methods used in section 3.3.1 on the 
distribution of WBAADC and WBAFA values across ages. These average values were plotted for each 
patient according to their age in days after each processing step. The patients were then grouped 
according to their age in months (0 month, 1-2 months, 3-4 months, etc.) and the standard 
deviation of WBAADC and WBAFA for each group was calculated. A decrease in standard deviations, 
before and after the data were processed, was expected by reducing the variability across patients 
due to non-brain tissue and artifacts. According to the literature (see part 2.2), an overall decrease 
of WBAADC values and an overall increase of WBAFA values across ages were also expected (see 
results part 4.2.1).  
 
 Subsequently, I tried to mathematically describe more precisely the time evolution profile of 
these indices, by applying different curve fitting methods to the data in order to see which function 
describes the data best.  
In this context, three different models were used (x = age, f(x) = estimated WBAADC or WBAFA): 
 
(1)  Linear:   xmhxf )(   (h, m constants) 
 
(2)  Logarithmic:  )ln()( xbaxf      (a, b constants) 
 
(3)  Biexponential: t
x
s
x
eqepxf  )(  (p, s, q, t constants) 
 
I decided to use the logarithmic and biexponential models as suggested in previous studies 
(Löbel et al., 2009 and Muhkerjee et al., 2001 respectively). All parametric fits were performed by 
the Curve Fitting Toolbox30 provided by Matlab. A standard linear least square method was used to 
estimate the parameters in linear equations and a nonlinear least square method to estimate the 
parameters in logarithmic and biexponential equations.  
                                               
30 See Curve Fitting Toolbox manual in pdf format : 
http://hug.phys.huji.ac.il/PHYS_HUG/MAABADA/Mabada_b/curve%20fitting%20in%20Matlab.pdf 
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R-square (R2) fit statistics were used to compare the models and determine the best one. This 
statistic measures how successful a fit is in explaining the variation of the data. Resulting R2 values 
fall between 0 and 1, a value closer to 1 indicating a better fit. Let’s say that we obtain an R2 = 0.81 
for a particular fit, this means that this fit explains 81% of the total variation in the data around the 
average. 
Prediction bounds for the fitted function and for new observations were also included. To 
understand these two concepts, we can take the example of a curve that fit the WBAADC values 
across ages. The 95% confidence prediction bounds for the fitted function denote the range of 
WBAADC values at each age where the true mean WBAADC value for that age range should be within 
95% certainty. The 95% confidence predictions bounds for new observations represent the range of 
WBAADC values at each age within which the WBAADC value for a new individual of that age, taken 
from this population, can be determined with 95% certainty. In other words, this interval indicates 
that we have 95% chance that the new observation is actually contained within these lower and 
upper prediction bounds (see results part 4.2.2).  
 
Then, a General Linear Model (GLM) including Age (days from birth) as a continuous predictor 
and Gender (Male/Female) as a categorical predictor was used in order to examine the effect of 
these variables and their interaction on WBAADC and WBAFA (see results, 4.2.3). As time evolution 
of WBAADC and WBAFA values did not seem to follow a linear model, but rather a logarithmic or 
biexponential model, the GLM was applied after transforming Age and WBA values using natural 
logarithms (i.e., ln(Age) and ln(WBA)) (see results, 4.2.3). These analyses were performed using 
Statistica v.10 software (StatSoft, Tulsa, OK, USA). 
 
Finally, as mentioned previously, I also looked for longitudinal data of patients with multiple 
scans at different ages and they were used as controls for within subject time evolution of the 
diffusion indices. Four patients with multiple scans were found and highlighted in the WBAADC and 
WBAFA age evolution plot (see results part 4.2.4). 
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4. Results 
 
In this results section, I will first present the results acquired from the step-by-step database 
mining process resulting from the RPDR query (see part 4.1.1), then discuss the corresponding 
Access database medical information (see part 4.1.2), and finally the scan parameters of the data 
retrieved from PACS (see parts 4.1.3 & 4.1.4). 
I will then focus my attention on the results obtained from the data analysis investigating cross-
patient time evolution of different diffusion indices between the ages of 0 and 2 years (see part 
4.2). 
 
4.1. Database mining (Medical informatics) 
 
4.1.1. RPDR query 
 
The RPDR query described in part 3.2.1 was run on the 5th of November 2010 and the resulting 
aggregate numbers are shown in the bottom right quadrant of Figure 11 (the screenshot displayed 
in Figure 11 is not the actual query requested at that time (note the dates do not match), but 
rather the query was run again with the same criteria and parameters for the sake of this report to 
obtain the screen shot. 
Note the aggregate number of patients satisfying our selection criteria, namely patients who 
had a brain MRI scan at the age of 0 to 6 years since 2000 and who don’t have any HIV history. We 
obtained 6886 ± 3 patients who met these criteria (restraining this query to patients from 0 to 2 
years of age, we obtained 5278 patients). This number was a rough estimate of how much data 
might be of interest in the context of this project. We have to keep in mind that it also included 
patients who were older than the age range of interest and that some patients may not have 
undergone an MRI scan that included the modality we were interested in (i.e. diffusion imaging). 
This number gradually decreased as we refined the query in the following steps. 
The distribution of gender in this population was 44% female and 56% male with the following 
ethnic distribution: 66.8% White, 13.4% Hispanic, 5.9% Black, 3.9% Asian and 10% Other/Unknown. 
Finally, at the time of the query, 98% of the patients were still alive. 
 
4.1.2. Microsoft Access Database queries 
 
As explained in part 3.2.2, the Access Database retrieved from RPDR enables us to refine our 
queries after obtaining additional medical information regarding the patients. This information was 
extracted before any data were retrieved from PACS. Therefore, it gave us some crucial 
information about the data potentially available from PACS and helped focus our attention on the 
most valuable and interesting studies. 
  
  Results 
   
- 40 - 
4.1.2.1. Number of brain MRI scan for each age range 
In the first step, I limited the query to patients aged 0 to 6 years (0 to 72 months) at the time of 
the scan and whose procedures were included in Table 1 using SQL methods explained in part 
3.2.2. Doing so, the aggregate number of unique patients obtained dropped from 6886 to 3044.  
However, when the total number of scans that met the criteria was considered (i.e. taking into 
account that some of these patients had several scans at different ages), I found a total number of 
4272 brain MRI scans that met the inclusion criteria. 
Looking at the distribution of the scans according to the age of the patients at the time of the 
scan, I obtained the histogram displayed in Figure 17A. 
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Figure 17: Number of patients who had a brain MRI scan at a particular age in months from 0 to 6 years (A) and in 
weeks from 0 to 4 months (B). 
 
From this figure, it is clear that the distribution of the number of patients with a brain MRI scan 
is on average homogenous across different ages except from 0 to 4 months where there are more 
scans. After 4 months, the average number of brain MRI scans per month remains constant (mean 
= 49, std = 10.02) (data from 0 to 4 months is not included in this average). By looking more 
precisely (in weeks) at the distribution of scans between 0 and 4 months (see Figure 17B), we 
notice that a predominant number of scans were made in newborns within the first days of life 
(first 2 weeks).  This is expected given that the predominant indication for pediatric neuroimaging 
is complications at the time of birth (e.g. traumatic birth with suspected ischemia or seizures or 
some abnormality in the neonates’ anatomy or behavior). 
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4.1.2.2. Proportion of MRIs that include diffusion imaging 
Using the keyword criteria selection, using words related to diffusion images used by physicians 
in radiology reports (see part 3.2.2.2), I was able to approximate the proportion of these scans that 
likely included diffusion images. Figure 18 displays the proportion of brain MRI scans that contain 
diffusion imaging (in blue) and the proportion of undetermined scans (in orange).  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 1-2 3-4 5-6 7-8 9-10 11-12 13-14 15-16 17-18 19-20 21-22 23-24
Age [months]
Sc
an
 p
ro
po
rti
on
undetermined
diffusion
A B
diffusion
70%
undetermined
30%
 
Figure 18: Proportion of Diffusion brain MRI scans from 0 to 24 months. The blue portion represents the scans that 
include diffusion criteria and the orange portion represents the remaining brain MRI scans (A); average proportion 
of diffusion and undetermined scans over 0 to 24 months (B). 
 
The age-range from 0 to 24 months is shown for simplicity, but this proportion stays more or 
less constant across different age ranges, with an average of 70% diffusion scans. However, the 
fact that no diffusion-related term is used by the physicians in a radiology report description 
doesn’t necessarily imply that this scan doesn’t contain diffusion imaging; the percentage of MRI 
data containing diffusion imaging may be higher than expected as we will see in part 4.1.4. 
 
4.1.2.3. How old are the scans? 
Another interesting information that can be queried from the Microsoft Access database is the 
proportion of the scans acquired at different time periods (years) for the reasons explained in part 
3.2.2.3 & 3.2.5. Figure 19A displays the proportion of scans that were completed before 2006 and 
after 2006 for each age range (from 0 to 24 months). Figure 19B shows the overall distribution of 
these scans for each year from 2000 to 2010.  
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Figure 19: Proportion of scans acquired before the year 2006 (blue) and after 2006 (magenta) (A) and overall 
distribution of these scans for each year from 2000 to 2010. 
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It is clear that the scans are fairly evenly distributed across the age range within different years. 
The proportion of 2010 scans relative to the total number of scans is fewer in comparison to other 
years since our database contains only scans completed before August 2010. 
In addition, a large proportion of the scans (55%) were acquired before the year 2006, where 
we decided to focus our attention.  
 
4.1.2.4. “Normal” or “Abnormal” brain MRI scan? 
At the time of this report, I manually reviewed more than 1500 radiology reports (out of 2111) 
from patients aged 0 to 24 months at the time of the scan and tagged them according to criteria 
explained in part 3.2.2.4. So far, all the patients from 0 to 12 months old have been classified and 
their proportion are displayed in Figure 20A; the average proportion of “normal”, “abnormal” and 
“undefined” patients from 0 to 12 months is displayed in Figure 20B. 
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Figure 20: Distribution (A) and average proportion (B) of “normal”, “abnormal” and “undefined” patients across the 
ages of 0 to 12 months. 
 
We noticed that on average 33% of patients have “normal” outcomes from their radiology 
report meaning that no major brain abnormalities were detected by physicians for these patients.  
 
4.1.2.5. Longitudinal data 
We were interested in investigating patients with multiple MRI scans at different time points for 
longitudinal investigations. As explained in part 3.2.2.5, we used a VB script to present the data in a 
more comprehensive way that includes additional information about the scans; we looked at 
patients between the ages of 0 and 6 years (see Table 3). 
Looking at these results, we note that 493 patients had more than one scan (ranging from 2 to 
17 scans). As mentioned in part 3.2.2, a query of CT scans was also constructed in order to obtain 
supplementary information about the MRI. A table only including CT-related procedures (cf. 
method explained in part 3.2.2.1 for brain MRI-related procedures) was generated using 15 
different CT-related Codes as criteria. Then, by linking the brain MRI-related and CT-related tables 
by their Encounter_Number and their MRN field, a list of patients having both brain MRI and CT 
procedures during the same encounter was obtained. From this list, and using the VB script, this 
information could be integrated in Table 3 by highlighting in yellow brain MRI scans with a 
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corresponding CT scan. This additional information could be useful either for registration purposes 
or further investigations in the future. 
 
 
Table 3: This table displays a subset of the data because the complete data set could not fit on a regular page. The 
first column contains the MRN. The furthest right column indicates the number of brain MRI scans each patient had 
and the bottom rows partially delineate the age range from 0 to 72 months. The circles specify the scans containing 
diffusion imaging and the crosses are the undetermined brain MRI scans (see part 4.1.2.2). The yellow highlighting 
indicates MRI scans that have a corresponding CT scan. Finally, the number in the lower left corner corresponds to 
the total number of patients having more than one scan and the lower right corner corresponds to the total number 
of scans for these patients.  Note that due to HIPAA regulations, the MRNs have been altered for the purposes of 
this Figure. 
 
Thus, the data we have at our disposal contains a considerable amount of longitudinal 
information, which could be valuable for further analysis. Notably, I found and used some of this 
longitudinal data as a within-subjects control for our time-evolution analysis of diffusion indices 
(see part 4.2.4). 
 
From the RPDR Access database alone, I was able to roughly estimate the number of potential 
studies we were interested in, to wit, studies from normal patients aged 0 to 2 years with diffusion 
scans acquired from the year 2000 to 2005. Out of 2111 studies identified for that age range, at 
least 70% contained diffusion series, 55% were acquired before the year 2006 and 33% were 
defined as normal. This left us with an estimation of 268 studies meeting the selection criteria.  
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4.1.3. PACS retrieval 
 
All previous results were based only on the output from the RPDR query with no additional 
information from the medical images themselves or from an interaction with the PACS.  The next 
steps were performed with access to the imaging data that enabled me to refine the criteria 
because I knew exactly what series each study contained, rather than speculating based on the 
incomplete information in the previous Access database. 
To date we have retrieved 1646 studies out of the 2111 studies I identified with the Access 
database retrieved from RPDR. These studies correspond to patients aged 0 to 24 months at the 
time of the scan and were retrieved from the MGH PACS. All of the studies from patients aged 0 to 
12 months were requested and all the remaining studies are currently being requested through the 
mi2b2 prototype software. Thus, the following results are based on patients aged 0 to 12 months 
(Figure 21), but they are also representative of the data we will be able to obtain for full age range 
(0 to 24 months). 
 
 Age [months] Total # of studies Retrieved from PACS Not available
0 531 515 16
1 107 104 3
2 104 101 3
3 116 105 11
4 90 85 5
5 57 55 2
6 60 57 3
7 57 53 4
8 53 48 5
9 58 53 5
10 63 58 5
11 48 44 4
12 65 62 3
Total 1409 1340 69
Retrieved from PACS
95%
Not available
5%
 
Figure 21: Table summarizes, the total number of studies identified, the corresponding number of studies 
successfully retrieved from PACS and the number of studies not available, for each age range. The average 
proportion is displayed in the pie chart (right). 
 
Using the prototype of mi2b2 software, 95% of the studies present in the Access database were 
successfully retrieved. The remaining 5% were either not found in PACS through the mi2b2 
prototype, or failed in the downloading process due to technical issues. Studies that failed to 
download from PACS were re-requested up to three times, after which point they were considered 
as not available for this thesis. This retrieval failure was at least in part if not totally due to task and 
cache management limitations of the mi2b2 software that govern the interaction between the 
PACS and mi2b2 cell.  This project highlighted this critical limitation of the mi2b2 software design 
and resulted in significant improvements in the subsequent version of the software that is just now 
being deployed and will be tested later this summer. 
 
4.1.4. Data of interest 
 
By extracting the technical information from the PACS retrieved images and adding them to the 
Access database as described in part 3.2.4, I was able to refine the query to its final stage. This 
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allowed the identification of the diffusion imaging data actually used for the time-evolution 
analysis of the diffusion indices across ages. 
First, we examine the actual proportion of studies including diffusion scans to see whether the 
estimation stated in part 4.1.2.2 was accurate. Using the technical scan information (e.g. “series 
description”) from the studies retrieved from PACS and the Access database, I could precisely 
determine the percentage of studies that actually contained diffusion images (see Figure 22). 
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Figure 22: Actual proportion of Diffusion brain MRI scans from 0 to 24 months. The blue portion represents the 
scans that include diffusion criteria and the orange portion represents the remaining brain MRI scans (A); average 
proportion of diffusion and no diffusion scans over 0 to 24 months (B). 
 
We note that nearly all of the studies collected (92%, 1515 studies out of the 1646 retrieved from 
PACS) actually contained diffusion images, which is exactly what our collaborator Ellen Grant 
predicted based on her intimate knowledge of the clinical scan acquisition protocols; however, this 
proportion is much greater than was expected based only on the medical information available in 
RPDR (see part 4.1.2.2, Figure 18).  This limitation of the information available in RPDR for this level 
of detail of the scan acquisition is not easy to address given the current system of medical 
informatics at our institutions, but this project will help move the system in the right direction.  
Having confirmed that most of the imaging studies include diffusion scans, the selection criteria 
had to be constrained even more at that point. The desired search criteria included: 
 
“Any comparable diffusion imaging data of patients between the ages of 0 to 24 months who 
don’t present any major brain abnormality” 
 
The age range and the health status could easily be identified using methods explained in the 
previous chapters. Then, linking the procedure table with the newly added table containing scan 
details (see part 3.2.4, step 6) by their MRNs and study dates, I was able to select only information 
about patients whose corresponding images were retrieved from PACS.  
The “comparable diffusion imaging data” criterion, on the other hand, was more complicated to 
define. As explained in part 3.2.5, we decided to focus our attention on diffusion data acquired 
before the year 2006 when diffusion scans were more consistent in terms of quality and sequence 
parameters across patients. However, even within this subset of data, I encountered some 
variation in sequence parameters. The following is an example of a study with different set of 
diffusion parameters (Table 4): 
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Table 4: Scan details about a particular study. Magnetic field strength is displayed in mT, TR and TE in ms, rows, 
columns, pixel spacing, slice thickness in mm and bandwidth in Hz/pixel. Series number is specific for each series 
within a study (see part 3.2.4 (2)). Uncolored rows represent non-diffusion data and colored ones indicate diffusion 
sequences. 
 
Two main problems arose when I looked more precisely at the diffusion data stored in the PACS. 
First, and most importantly, in most studies, the raw diffusion data (from which the diffusion 
tensor matrix and the related diffusion indices are computed, see part 2.1) were not available, 
unlike the example presented in Table 4 (e.g. “DWI raw b=1000”). The decision in the radiology 
department was to store only volumes from the already computed diffusion indices (DWI average, 
ADC average and FA, see Table 4). Thus we could not compute these indices with the algorithms of 
our choice.  
The other issue was that b-value information for each sampled direction was unfortunately not 
available from the DICOM headers. To date, the leadership within the DICOM standards 
consortium has not yet led the field to include this important image acquisition parameter in the 
DICOM header, as it is still considered a proprietary field of information.  As explained earlier, the 
main criterion, in terms of comparability of diffusion scan measures, was to have similar b-values.  
Thus I had to find an alternative way to figure out what the b-values were for each series. Dr. Ellen 
Grant informed me that they used 3 different sets of values at that time, the longer the TE, the 
higher the b-value. This information could me confirmed looking at some studies whose raw 
diffusion data were available and whose b-values were included in the series description name 
(Table 4). In this particular example, 3 different diffusion sequences were acquired (cf. 3 colors) 
with the 3 different b-values and the corresponding TEs: b = 700 [s/mm2], TE = 93.4 [ms]; b = 1000 
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[s/mm2], TE = 101.3 [ms]; b = 1500 [s/mm2], TE = 111.4 [ms]. Using this information, I could 
determine which TE was used the most and subsequently infer its corresponding b-value (Figure 
23). 
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Figure 23: Distribution of diffusion scans according to their TE in ms. This graph includes all of the diffusion data we 
had at our disposal that were acquired with the “old” (prior to 2006) diffusion protocol (n = 2371). 
 
As expected, we notice three main different TE clusters, one around 93 [ms], one around 100 [ms] 
and one around 111 [ms] with corresponding b-values of 700, 1000 and 1500 [s/mm2] respectively. 
We also note that most diffusion scans (72%) were acquired with a TE near 100±3 [ms]. Looking at 
all of the raw diffusion data with b-values included in the name of the series, I could conclude with 
almost 100 percent confidence that all diffusion data with TE >= 97.4 [ms] and TE <= 108 [ms] were 
acquired with the same b-value of 1000 [s/mm2]. Therefore, I decided to constrain our diffusion 
data of interest to those within this TE range, where most of the studies are found. As a result, the 
b-value comparability criterion can be satisfied and minor differences in TEs, as explained 
previously, should only have minimal influence on calculated diffusion indices (see part 3.2.5). 
One last detail has to be mentioned.  I also came across studies with two different diffusion 
scans acquired with the same TE. Inspecting the corresponding volumes, I noticed that the volume 
with the lowest series number always had important artifacts that compromised the readability, 
and that the one with the highest series number was of better quality. Dr. Ellen Grant later 
confirmed that a second diffusion scan with same sequence parameters as a previous one could 
have been acquired when the first one was of poor quality due to patient motion or other causes. 
For that reason, I decided to systematically select the second series (i.e. the one with the higher 
series number), when two series were acquired with similar parameters within one study. 
To meet the goals of this project, only scans that included previously computed ADC, LOWB (b0 
reference) and FA values were investigated. Unique series numbers, representative of the “old” 
scan parameters, were used to filter the data to only include scan obtained using the “old” 
diffusion protocol. These series were selected using the following series numbers: 
 
ADC : 101, 106, 111, etc. (+ multiple of 5) 
LOWB : 102, 107, 112, etc. 
FA : 104, 109, 114, etc. 
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After these considerations, I was finally able to identify and select all of the scans needed for 
further data analysis that fell under the final and most restricted selection criteria: 
 
“Comparable (97.4 [ms] <= TE <= 108 [ms]) diffusion imaging data (ADC, LOWB and FA with 
corresponding specific highest series numbers) of patients between the ages of 0 to 24 months 
who don’t present any major brain abnormality (i.e. whose corresponding health status = normal)” 
 
This can be done using the enhanced Access database containing the health status tags and the 
series sequence parameters by linking Demographic, Procedures, Scan Parameters and Health 
Status tables and constraining the search with the criteria of interest. 255 different series fulfilling 
these criteria were obtained (see distribution in Figure 24). This Access database query generated 
the list of MRNs with corresponding dates and series numbers that was used to automatically 
retrieve the data from the NIfTI working directory and copy them to a separate directory used for 
data analysis.  
All ADC and FA volumes, analyzed together for each subject, were visually inspected using the 
Freeview31 visualization tool. The FA index, as opposed to the ADC index, is more sensitive to 
artifacts (such as motion) due to its directionality specificity (in contrast, the ADC index is simply 
the average diffusion in any direction). Thus, the FA volumes were first inspected, followed by the 
corresponding ADC volume. Volumes were discarded when structures usually seen on FA images 
could not be distinguished (due to excess blurring) or when important changes in brightness from 
slice to slice were noticed (probably due to motion artifacts). The corresponding ADC volumes in 
these cases were also often blurry (to a lesser extent for the reasons explained above), and were 
also discarded. 
After this visual inspection, 61 series (FA and corresponding ADC volumes) had to be discarded 
due to insufficient quality or major artifacts. This resulted in a total number of 193 useable series 
(193 ADC volumes and 193 corresponding FA volumes) for our further analysis (see distribution 
Figure 24). 
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Figure 24: Total number of studies falling under data of interest criteria (selected + discarded) for each age range 
from 0 to 24 months. In orange, the number of series discarded for insufficient quality and in green the number of 
study selected for further analysis. 
   
                                               
31 http://surfer.nmr.mgh.harvard.edu/fswiki/FreeviewGuide/FreeviewIntroduction 
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A larger proportion of studies were discarded in the age ranges of 0 and 1 month. This was due 
to difficulties (patient motion, very small head size) encountered when scanning very young 
patients (newborns). Many studies were not available or not yet classified after the age of 12 
months, explaining the reduction of the number of series from 13 to 24 months. 
 
Finally, all these selected MR diffusion scans were acquired at MGH on a 1.5 Tesla scanner (GE 
Medical System) with the standard scanning sequence and with the following parameters: six 
different encoding directions with b-values of 0 and 1000 [s/mm2]; TE = 97.4 - 108 [ms]; TR = 6000 
or 7500 [ms]; matrix 128×128 [mm]; voxel size = 1.72×1.72, 1.56×1.56 [mm] or 1.41×1.41 [mm]. 23 
slices (a few between 17 and 22) were acquired across the brain with thicknesses of 3-6 [mm] and 
gap of 1 [mm]. Calculations of eigenvalues, diffusion tensor matrices and corresponding ADC and 
FA were performed by the proprietary scan vendor software as part of the clinical image 
processing done by the department of radiology. 
The slight differences in acquisition parameters across patients were due to specific 
adjustments made by the pediatric neuroradiology department faculty at MGH to optimize the 
quality of the MR images according to each patient. The variability was further exacerbated by the 
inevitable and desired changes due to scanner hardware and software upgrades.   
 
Of the 2111 studies identified in the Access database from patients aged 0 to 24 months, we 
successfully retrieved 1646 studies from PACS using the mi2b2 software. Of these, 476 were 
categorized as normal. Selecting the data acquired with the old diffusion sequence parameters 
further reduced the number of studies to 273. Finally, the TEs selection criteria reduced this cohort 
to 255 comparable diffusion studies and 62 studies had to be discarded for quality issues. Thus our 
final data set was comprised of 193 comparable studies. 
 
4.2. Time evolution of diffusion indices across ages 
 
4.2.1. Data processing 
 
To investigate the effect and effectiveness of the data processing (see part 3.3.1, Figure 16) in 
reducing artifacts and removing non-brain tissue on the distribution of WBAADC and WBAFA values 
across ages, the WBAADC and WBAFA values were plotted after each stage of image processing 
(Figure 25 & Figure 26, respectively).  
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Figure 25: Distribution of WBAADC [mm
2/S] across age in days from non-processed data (A); after the brain extracted 
LOWB masking (step 2 of Figure 16) (B); after threshold application to remove CSF (step 3 of Figure 16) (C); and after 
BET application to ADC volumes (step 4 of Figure 16) (D). 
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Figure 26: Distribution of WBAFA across ages [days] from non-processed data (A), after brain extracted LOWB 
masking (step (2) applied to FA volumes, Figure 16) (B), after threshold application to remove CSF (step (3), ADC 
volume mask applied to corresponding FA volume, Figure 16) (C) and after fully processed ADC volume masking  
(step (6), Figure 16) (D). 
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As expected, WBAADC values seem to decrease whereas WBAFA values seem to increase with age 
(quantitative analysis of the evolution will be performed in following chapters). We also note an 
overall decrease in WBAADC and WBAFA values before (pre-) and after (pos-) the data were 
processed (pre-WBAADC average = 1.4×10-3 [mm2/s], std = 1.304×10-4 and post-WBAADC average = 
1.19×10-3 [mm2/s], std = 1.228×10-4 ; pre-WBAFA average = 0.327, std =  0.025 and post-WBAFA 
average = 0.271, std = 0.031). 
In addition we notice that data processing greatly reduced the variability of WBAADC and, to a 
lesser extent, WBAFA. The most important variability reduction in WBAADC values occurred with the 
CSF removal step (Figure 25, C), the other steps had less influence. Standard deviations of WBAADC 
and WBAFA values were calculated for each age range (0-24 months) before and after data 
processing (Figure 27, A-B). The difference in standard deviations before and after data processing 
was also determined (see Figure 27, C-D). 
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Figure 27: Standard deviation of WBAADC and WBAFA values for each age range, (A) and (B) respectively before (blue) 
and after (yellow) data processing. Difference in standard deviation for each age range, (C) and (D), negative values 
represent a decrease in standard deviation after data processing. 
 
As expected, the data processing tends to decrease the standard deviations of WBAADC values 
for each age range, except for 1-2 months (Figure 27, A, C) and to a lesser extent the standard 
deviations of WBAFA values except for 5-6, 7-9, 11-12 and 19-20 age ranges (Figure 27, B, D). In 
addition, the standard deviation of processed WBAADC seems to decrease with age meaning that 
variability of these values is greater at an early age. 
 
4.2.2. Curve fitting analysis 
 
Three different curve fitting models (linear, logarithmic and biexponential) were applied to the 
data in order to see which function described the data best (see description part 3.3.2) by 
comparing the R2 fit statistics for each model (see Figure 28 for WBAADC fitting and Figure 29 for 
WBAFA fitting).  
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Figure 28: Curve fits for WBAADC values across ages. With no fit (A), with linear (B), logarithmic (C) and biexponential 
(D) fits. Prediction bounds at 95% confidence for the function (dashed lines) and new observations (dotted lines) and 
R2 values are also displayed for each model. (Estimated parameters are available in Appendix 8.9) 
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Figure 29: Curve fits for WBAFA values across ages. With no fit (A), with linear (B), logarithmic (C) and biexponential 
(D) fittings. Prediction bounds at 95% confidence for the function (dashed lines) and new observations (dotted lines) 
and R2 values are also displayed for each model.  (Estimated parameters are available in Appendix 8.9) 
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From a preliminary visual inspection, we can already determine that the logarithmic and 
biexponential equations result in a better fit model for the time evolution of both WBAADC and 
WBAFA values. This is confirmed by the R2 values which are higher in these two models than in the 
linear one. The linear model, although revealing the main trend (decrease in WBAADC and increase 
in WBAFA values), does not seem to reflect the shape of these evolutions. We also observe that in 
both cases, R2 values are the highest in the biexponential model, suggesting that this model would 
best describe the time evolution of WBAADC and WBAFA values across ages. In this model, we 
obtained an R2 of 0.875 for WBAADC and 0.462 for WBAFA values. This indicates that this fit explains 
87.5% and 46.2% of variability about the average in the WBAADC and WBAFA values, respectively. 
Predictions bounds at 95% confidence for the functions and for new observations are also 
displayed (dashed and dotted lines respectively). 
 
4.2.3. GLM analysis 
 
The GLM was used to estimate the effects of Age and Gender on WBAADC and WBAFA. In this 
case, it is an Analysis of Covariance (ANCOVA) since we have a continuous outcome variable (either 
WBAADC or WBAFA), one continuous predictor variable (Age in days) and one categorical predictor 
variable. As mentioned in part 3.3.2, Age and WBA values were first log-transformed in order to 
improve linearity of the age-WBA relationship.  We note that the linear curve fits have higher R2 
values when performed on the transformed data (Figure 30) than the original data (Figure 28, B 
and Figure 29, B). 
 
R2 = 0.4005
A B
R2 = 0.8204
 
Figure 30: Natural logarithm of WBAADC (A) and WBAFA (B) versus natural logarithm of Age. Black lines represent 
linear fits with the corresponding R2 values. 
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As expected, the GLM revealed a statistically significant effect of Age on WBAADC values, F(1,189) = 
895.0, p < 0.0001, and on WBAFA values, F(1,189) = 126.7, p < 0.0001. In addition, a significant effect 
of Gender (Female, N=82 and Male, N=111) on WBAADC values was observed, F(1,189) = 8.7, p = 
0.0038, as well as a significant interaction between Gender and Age, F(1,189) = 5.2, p = 0.0236. This 
indicates that Gender significantly influences the way WBAADC values evolve with Age (i.e. the slope 
of the curve in such a linear model). An examination of Figure 31A reveals that WBAADC values 
seem to be slightly higher in Males than in Females at an early stage, but become more similar with 
increasing age.  
No significant effects of Gender on WBAFA values and no significant interactions between 
Gender and Age were observed, F(1,189) = 1.15, p = 0.2859 and F(1,189) = 0.28, p = 0.5973, respectively 
(Figure 31, B). 
 
A B
R2
F
 = 0.8623
R2
M
 = 0.8083
R2
F
 = 0.4730
R2
M
 = 0.3660
 
Figure 31: Natural logarithm of WBAADC (A) and WBAFA (B) versus natural logarithm of Age separated according to 
Gender (Female orange and blue circles, Male green and red squares for WBAADC and WBAFA respectively). 
Corresponding color-coded linear fits with corresponding R2 values are also displayed. 
 
4.2.4. Within patient WBA ADC/FA time evolution controls  
 
As explained previously, we also looked for patients with multiple scans that could be used as 
controls for within patient time evolution of WBAADC and WBAFA values. Four individual patients 
were found each of whom had multiple diffusion MRI scans acquired at different ages. Three of 
them were followed for non-brain tumors (retinoblastoma) and one for hypoglycemic seizures. In 
all cases, there was no reported imaging evidence of abnormal brain development in the 
corresponding radiology reports. These patients were highlighted in WBAADC and WBAFA value plots 
and images of one index patient were also included (see Figure 32 & Figure 33). 
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Figure 32: Four patients with multiple scans are highlighted in orange (11 and 66 days), green (44 and 199 days), 
blue (82, 406, 588 and 769 days) and red (99, 190, 286, 414 and 726 days). Corresponding processed ADC images of 
the patient displayed in red color are included. The 95% prediction bounds for new observations in the 
biexponential model are also displayed (dashed lines). 
 
 
Figure 33: Four patients with multiple scans are highlighted in orange (11 and 66 days), green (44 and 199 days), 
blue (82, 406, 588 and 769 days) and red (99, 190, 286, 414 and 726 days). Corresponding processed FA images of 
the patient displayed in red color are included. The 95% prediction bounds for new observations in the 
biexponential model are also displayed (dashed lines). 
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For both WBAADC and WBAFA, we observe an overall decrease and increase respectively, of these 
values within patients across ages (with the exception of the “red” and “blue” patients whose 
WBAFA values decrease between the age of 99-190 days and 406-588 days respectively). Consistent 
with the best fit (biexponential model) and the literature in the field, the rates of change are most 
rapid during the first weeks of life (see Figure 32 & Figure 33, orange and green for example) as 
assessed by the slope of those lines. 
Changes in ADC and FA images can be noticed even visually with a darkening trend in ADC 
images, especially in white matter (see Figure 32), and a prominent evolution of fiber bundle 
delineation in FA images (see Figure 33). 
  
  Discussion 
   
- 58 - 
5. Discussion 
 
5.1. Database mining 
 
The first part of this project was dedicated to database mining with the aim of identifying and 
retrieving biomedical MRI data from MGH PACS that met the following criteria: 
 
“All comparable diffusion imaging data of patients between the ages of 0 to 24 months without 
any major brain abnormality” 
 
I started this data mining expedition with 5278 potential patients with brain MRI scans from 
RPDR finished with “only” 193 studies in the final cohort (less than 3.7% of the total). This number 
might seem very low, but actually resulted in a cohort size that is significantly larger and more 
evenly distributed across the age range than what has been available so far in similar research in 
this same age range (see 2.2). Moreover, the time required to acquire the imaging data, from time 
of IRB approval to retrieval from the PACS was about 3 months worth of work (without accounting 
for mi2b2 troubleshooting time), including the time required for data mining. Most importantly, 
this valuable data was accessed at the costs of the data storage and personnel time; a vanishingly 
small fraction of the costs associated with a prospective study that aimed to collect this data set by 
recruiting and scanning healthy babies.  This was only possible using biomedical data collected at 
MGH over the last decade and tools that were developed to retrieve those data. 
In this pilot project, I demonstrated the possibility for researchers to use available tools such as 
RPDR and its Access database to identify any data of interest in order to retrieve them from MGH 
PACS with the help of the newly developed mi2b2 software. This infrastructure has been 
intensively developed for the past 2 years and the Production version of the mi2b2 software will be 
released to the Partners user community in the Fall of 2011.  
As a new (and first) user of the mi2b2 software, I was able to investigate the possibilities for the 
use of this software once the imaging data were retrieved from the hospital database. My efforts 
have greatly helped the developers to design a user interface for mi2b2 that facilitates retrieval 
and post-retrieval investigation. In fact, as I was retrieving increasing numbers of MRI data sets 
from PACS, I realized early on that it would not be possible to work with such a large quantity of 
image data sets in their original format. Therefore, I developed the BB-pipeline that automatically 
organizes and reformats the data retrieved from PACS through mi2b2 in a way that facilitates 
identification, selection and further work on any data of interest. Certain functionalities of this 
pipeline, including Rudolph’s (see People section 8.3) system could be included in the mi2b2 
software, allowing the users to choose the output format of the data by including, MRNs, study 
dates, ages, etc., in the directory/file names. The automated DICOM header extraction regarding 
technical scan details used for further data filtering could also be used in future versions of the 
mi2b2 user interface to make life easier for the researcher. This was discussed with the mi2b2 
team during my project and was proposed in the RO1 grant application submitted in June 2011 (cf. 
Introduction): 
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“We will also develop a method to enhance the usage of the DICOM metadata present in the 
DICOM headers.  An automated process that extracts patient-, study-, and image-related fields 
from the DICOM header will contribute this information to a relational database where it too may 
be queried.  This will improve our filtering ability to select scans based upon specific details of scan 
acquisition.”32 
 
One main drawback of the pipeline that I’ve been developing was the use of an Access 
Database. As discussed previously, there was no direct connection between the imaging data 
sitting on my Linux workstation and the medical and technical information included in the PC based 
Access Database on my laptop computer. Hence, a manual transfer of text files was necessary to 
connect the two, a suboptimal method. A potential way to improve this system would be to set up 
a Linux compatible relational database management system (e.g. MySQL) directly on the 
workstation removing the inefficient manual step of text file transfer. Having such a set up would 
also make it possible to design a simple script/software that would take any criteria as input 
(medical or technical criteria, such as the ones described in this thesis) from a user and 
automatically retrieve the corresponding data. This would eliminate the burden of selecting data in 
the Access Database, extracting a text file with corresponding MRN or other identifiers, and 
manually transferring it to a workstation where a specific script reads them and retrieves the 
corresponding images. Additionally, any other useful features (such as imaging data format) could 
also be included in this script that would perform these functions automatically for the user. 
Developing such software would greatly enhance the manipulation of the data and facilitate the 
work of potential users. 
 
Having emphasized the importance of automating as many steps as possible of the database 
mining process, one particular step remained entirely manual. It was necessary to identify normal 
patients by reading through radiology reports. As we observed in part 3.2.2.4, radiology reports 
contain verbally dictated notes of the responsible radiologist that are not standardized and vary 
from case to case. Because of this, the only option was to read through each report individually. 
This process was extremely time consuming and I took several weeks to comb through the records 
of more than 1500 patients. Developing an automated way of detecting normal cases would, in 
consequence, be a very helpful addition to the data mining process. One way of tackling this 
problem would be to use machine learning methods, using the complete list of key sentences 
collected in normal cases (see part 3.2.2.4) as training data. Nick Murphy, graduate student at 
Harvard University, is currently testing a machine learning method33 on the data that I have already 
classified. He was able to get the system to correctly predict the classification of patient (“normal” 
or “abnormal”) about 70% of the time. The success of this preliminary program relied on previously 
manually classified studies, but it could be helpful for further identification of normal cases with 
some additional work. 
 
Another issue that has to be addressed is the comparability selection criteria that we applied to 
our diffusion data. As described in the Background chapter (part 2.1), quantitative metrics from 
                                               
32 RO1 grant application submitted in June 2011 requesting funds to further for the development of mi2b2 and to 
develop a novel Harvard Catalyst Radiological Decision Support (RDS) Toolkit 
33 http://www.cs.waikato.ac.nz/ml/weka/ 
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diffusion images depend on scan sequence parameters and consequently, only images with similar 
parameters can be directly compared without additional image post-processing or more complex 
statistical models. This reduced our “normal” patient cohort by 43% (from 476 to 273) when we 
decided to only focus on data acquired before the year 2006 (i.e. with the “old” diffusion sequence 
protocol). The TEs selection criteria further reduced this cohort by 7% to 255 comparable diffusion 
studies of normal patients. Finding a way of including all the studies in the same analysis would 
greatly improve its power by having at least twice as many studies. White et al., 2011, presented a 
study on global white matter abnormalities in schizophrenia with diffusion tensor imaging data 
acquired at four different institutions with different sequence parameters (Field strength, TE, TR, 
b-values, diffusion directions, etc.). As expected, their work revealed a significant site difference in 
FA values. To reduce the effect of these site-related differences, they notably corrected their 
statistical analysis by using site as a covariate in their model (White et al., 2011). This approach 
would be one way to include the rest of our data in our statistical analysis, and increasing its 
power. Similar studies have been conducted to examine the impact of image acquisition variables 
on different structural data analysis (Jovicich et al., 2009) and the feasibility of using multisite data 
sets to investigate questions of scientific relevance by carefully taking into account Site in statistical 
analysis (Fennema-Notestine et al., 2007). 
 
5.2. Data analysis 
 
Despite the considerable amount of data we had to reject, we still ended up with 193 studies 
from patients with “normal brains” aged 0 to 2 years. This allowed us to investigate the cross 
sectional time evolution of two different diffusion imaging biomarkers, to wit, WBAADC and WBAFA 
values. 
The first step in computing these values was to remove any non-brain regions from all the 
volumes. The large number of volumes involved, and the limited time I had at my disposal meant 
that no manual editing options were feasible.  This factor drove the decision to use semi-
automated methods.  The automated pipeline described in part 3.3.1, which I developed with 
advice of our team members (see People section 8.3), worked well on most of the data for these 
purposes, as assessed by visual inspection as well as quantitative assessment. As a result, we 
observed an overall decrease of variability within age specific patient groups by removing non-
brain regions and other artifacts (cf. Figure 25, Figure 26 & Figure 27). The overall decrease of 
WBAADC values is likely due to the application of the threshold to remove CSF regions, which have 
the highest ADC values. We also observed a similar overall decrease in WBAFA values which seems 
at first glance contradictory. Indeed, FA values in CSF are supposed to be very low due to its non-
directional water diffusion property and its removal should increase WBAFA values. In fact, this 
drop in WBAFA does not occur after the threshold application step but rather after the first step of 
BET application to LOWB used as a mask on corresponding FA volumes (Figure 26, A-B). Indeed, a 
lot of artifacts with very high FA values were noticed outside of brain regions. As a consequence, 
removing them during the first step lowered the overall WBAFA values (BET application on LOWB 
tend to remove structures outside brain regions).  
In addition, the main reduction of variability for each age range seems to occur in accordance 
with the last observations, namely after CSF removal in ADC volumes and after the LOWB BET 
masking on FA volumes. This suggests that the main source of variability among ADC volume 
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resides in CSF-related regions, whereas in FA volume this variability would be due to artifacts found 
outside of brain regions. 
 Looking at some fully processed FA volumes (e.g. FA images presented in Figure 16 & Figure 
33), some very bright (high FA values) non-brain regions appear along the posterior edge of the 
brain. These could partially explain the higher variability among WBAFA values, even after full 
processing.  Additional steps in the processing pipeline to remove those artifacts could be explored 
to further reduce this source of variability. 
 
The curve fitting analysis revealed that both the age dependent evolution of WBAADC and WBAFA 
values seem to be described better by biexponential models (as suggested by Muhkerjee et al., 
2001, for several ROIs) than by linear or logarithmic models comparing the goodness of fits 
indicated by the R2 values (see Figure 28 & Figure 29). In fact, the biexponential models might be 
more adequate than the other ones in biologically interpreting the time evolution of both WBAADC 
and WBAFA. Indeed, it actually takes into account a two phase model with two different terms in 
the model, a fast component (first term in the equation: p*exp(-x/s)) and slow component (second 
term in the equation: q*exp(-x/t)) according to the estimated parameters which reflects the fast 
decay at an early age follow by a slower decay in WBAADC values and a fast increase followed by a 
slower increase in WBAFA values. This might be a way of interpreting the underlying biological 
process of myelination that is known to undergo greatest change within the first months of life (cf. 
Background, part 2.2). 
No model, as good as it can be, can ever be the true representation of the data since Mother 
Nature did/does not implement them as such in living beings.  We can only try to find a model that 
fits the data as well as possible in order to obtain a quantitative estimation of how a biological 
process evolves (in our case, how our two markers, WBAADC and WBAFA evolve with age), and 
maybe predict where a new observed value should be for a specific range (see Figure 28, Figure 
29). We investigated this by the using prediction bounds for new observations that give the range 
of WBAADC or WBAFA values at each age within which the WBAADC or WBAFA value for a new 
individual of that age, taken from this population, should be determined with 95% certainty. 
Having such age-specific markers with prediction bounds could be very valuable when comparing a 
new patient, with unknown health status, to the predictions bounds of the corresponding age and 
determining whether he/she fits into this range. If this patient is normal (as determined in our 
population cohort), we have 95% chance that he/she is actually included within the range of the 
prediction bounds. If not, this could be a first clue that something might developing abnormally 
compared to normal patients of the same age. 
GLM analysis indicated a significant effect of Age on both WBAADC and WBAFA. These results 
were largely expected, as it is well known that brain development implies widespread structural 
changes, including myelination of the white matter bundles. Intriguingly, our results also revealed 
significant effects of Gender on WBAADC and a significant interaction between Age and Gender. This 
finding suggests that even at a very early stage (first weeks after birth), the brain (as assessed by 
the WBAADC marker) may evolve differently between Males and Females. This observation has 
important implications in the creation of developmental markers from identified normative cases 
since those markers, in addition to being age-specific, should also probably be gender-specific if 
appropriate comparisons are to be made with clinical cases. 
The inclusion of within patient longitudinal data controls was particularly valuable when 
comparing their individual age-evolution with the cross-patient age evolution of WBAADC and 
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WBAFA since they were not affected by inter-patient variability. The four longitudinal patients 
exhibited similar trends to those observed across patients, with a rapid decrease of WBAADC values 
at an early age (see Figure 32, orange, green and first time points of red colored patient) followed 
by a slower decay (see Figure 32, last time points of red and blue colored patient). The within 
patient WBAFA values displayed less obvious results, particularly for the patient whose data is 
shown in red (Figure 33), where a decrease was observed from 99 to 190 days instead of the 
expected increase, as the main trend suggests. This observation may have been the result of 
artifacts and greater sensitivity of FA values that might have biased the true FA values of the 99 
days patient volumes, rather than reflecting a real biological process. However, we also detected 
more rapid changes at an early stage, especially in the patients identified in orange and green 
(Figure 33). Investigating within patient evolution of markers such as WBAADC and WBAFA is crucial 
to be able to compare a new patient of unknown health status with a cohort of normal patients. 
Indeed, the fact that the markers for this particular patient lie within the prediction ranges does 
not say anything about their relative evolution for the individual patient. Actually, even though 
specific makers could seem to be within the normal range, their relative position to other time 
points within the same patient could reveal an abnormal evolution. Obviously, such data, in a real 
clinical situation, do not always exist, but if they are available, they could be of significant value. 
This highlights the importance of investigating markers of evolution not only across patients, but 
also within individual patients, because these markers could offer an even more reliable approach 
for detecting abnormal cases. 
 
We have to keep in mind that our two markers (WBAADC or WBAFA values) are not very specific 
since they were obtained by calculating the whole brain average of ADC and FA values for each 
individual patient. Therefore, all the information contained in the ADC or FA volume (e.g. region, 
size, contrast, etc.) is condensed in a unique value for both ADC and FA. This one value is not 
specific enough to determine subtle time-specific evolution of particular brain regions of different 
sizes, for instance. This may also explain the high variability we obtained for our markers, especially 
in WBAFA, since FA values are more specific than ADC volumes by taking into account a dimension 
of directionality that ADC values do not (ADC values are simply the average of the diffusion). In 
order to obtain more robust and specific markers, with less variability across patients than what 
we obtained, region-specific ADC and FA averages have to be determined.  
Several studies have investigated the region-specific time evolution of ADC and FA indices in 
children (see part 2.2, Mukherjee et al., 2001 ; Hermoye et al., 2006 and Löbel et al., 2009). They 
observed similar trends with an overall decrease of ADC values and increase in FA for specific ROIs 
across ages, encountering the greatest change at an early age. The range of values we obtained for 
our markers, although we obtained only whole brain information, is comparable to the range 
obtained in these studies (ADC values starting around 1300 [mm2/s] and rapidly decreasing above 
1000 [mm2/s], and FA values starting from 0.2 rapidly increasing above 0.3). However, these 
previous studies only included a few subjects (from around 10 to 30) aged 0 to 2 years in 
comparison to the number of subjects we had (193 patients). Hence, at the cost of region 
specificity, we gained significant age resolution, especially in the range from 0 to 200 days, where 
our markers indicate the most dramatic changes. The power of this significant number of patients 
allowed us to track changes occurring in the brain, even with simple markers that probably would 
not have been possible to detect with fewer patients.  
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Obviously, investigating the time evolution of specific ROIs with the group of patients we have 
at our disposal would be even more interesting. Unfortunately due to the delay of my first access 
to the full cohort due to development of the mi2b2 software and the time limitations of my 
fellowship, I was not able to envisage any specific manual ROI determination within the allotted 
time. The ideal situation would be to have access to different tools that could automatically 
segment the brains of patients aged 0 to 2 years. Unfortunately such tools that could work on 
newborns and infants do not exist at this time, and dedicated researchers (such as Lilla Zollei, PhD, 
among others) are putting all their effort in developing and making them available. An alternative 
way would be to develop a robust normalization procedure (similar to the ones mentioned in 
Background section, part 2.3) that could align several volumes in an age-specific standard 
effectively. Doing so, manual delineation of ROIs would only be necessary in the standard spaces 
and could be directly applied to the registered volumes. One of the aims presented in the RO1 
grant application specifically targets these issues.  
The image data used in this pilot project were of relatively poor quality, sensitivity and 
resolution in comparison to what can be currently found in other leading institutions specialized in 
children’s care such as Children’s Hospital Boston (CHB) where Dr. Ellen Grant, MD, is the Director 
of the Fetal-Neonatal Neuroimaging and Developmental Science Center. Current MRI data acquired 
there notably involve a 3T scanner with 2mm isotropic DTI and 35 gradient directions. Additionally, 
CHB routinely scans more patients in this age range than MGH (in the year 2010 alone, the 
Department of Radiology archived brain MRI scans acquired for routine clinical care in 626 patients 
aged 0-1 years and 1,019 patients aged 1-4 years).  The aims of the recently submitted R01 grant 
focus on applying all the lessons learned from this pilot project to acquiring and analyzing these 
higher resolution pediatric MR brain scans.   
Ideally, new types of sequences should be developed and applied to the study of brain 
development, in order to investigate more subtle processes. In fact, as briefly mentioned in part 
2.2, DTI only gives information about the diffusivity of water molecules within the brain which can 
be influenced by multiple factors such as axonal density and size, fiber tract coherence, or 
membrane structure and permeability (Beaulieu, 2002), and not only by myelination as it is 
sometime interpreted. Therefore, if we want to study more precise developmental processes, like 
myelination, more specific MRI sequences have to be performed. A recent study from Deoni et al. 
provided “the first ever in vivo visualization of myelin maturation in healthy human infancy” (Deoni 
et al., 2011) using a new myelin-specific MRI technique. Although promising, it may take a long 
time before such techniques are available on the clinical scanners where our data come from. 
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6. Conclusion 
 
In this pilot project, I demonstrated, with the collaboration of researchers from multiple sites, 
the feasibility of identifying, retrieving, and analyzing pediatric clinical multimodal MRI data, using 
available tools and the prototype mi2b2 software. The aim of this project was to study normal 
human brain development from birth through 2 years of age as indexed by diffusion MRI. 
The huge amount of data retrieved from PACS through mi2b2 (more than 30,000 series from 
1646 studies) rendered any manual organization, identification and selection of particular series 
impossible and necessitated the development of a pipeline that could handle this volume of data. 
Therefore the BB-pipline was created to automatically receive studies from mi2b2 software, 
organize and convert them in suitable format, extract corresponding technical scan information 
and update a log file used to help the mi2b2 development team to keep track of potential issues.  
Starting from more than 5000 patients in RPDR with potential diffusion MRI scans acquired after 
the year 2000, 193 studies meeting all the necessary criteria (age, health status, MRI modality, 
comparability and quality) were identified and used for further investigation.   
Two markers were computed after an automated procedure to remove non-brain tissues and 
artifacts, developed for the sake of this project. GLM and curve fitting analysis revealed a 
significant decrease and increase of WBAADC and WBAFA values, respectively, across ages that seem 
to evolve differently according to gender. Moreover, these age evolutions appear to follow 
biexponential models with a higher change rate at an early age. Using prediction bounds for such 
age-specific markers could be very valuable when comparing a new patient, with health status to 
be determined, to the predictions bounds of the corresponding age and determining whether 
he/she fits into this range.  
The significant size of our patient cohort enabled us to detect subtle changes at an early stage, 
even using simple markers that do not contain region specific information. Further work will be 
necessary to design new markers addressing this issue. Additionally, quality, resolution, sensitivity 
of the data, and quantity could be further improved using the newest data acquired in other 
institutions. 
All these concerns have been addressed in the R01 grant application submitted last June and if 
funded (I’m sure it will), will be tackled by dedicated researchers next year. I can leave knowing this 
project is in good hands, and confident of its success.  
 
This project has been extremely fruitful for my personal experience. Starting last September, I 
did not have much practical skills in the neuroscience field. Almost one year later, I have gained an 
insight into many different facets of the research world, including database management, different 
programming languages, clinical practices and politics, MRI research, and much more. This 
opportunity has helped me learn new skills, and explore clinical translational neuroimaging 
research. I have realized that, more than pure theoretical knowledge, EPFL provided me the 
necessary tools to adapt to this multi-disciplinary environment, that have been integral to the 
success of my project. 
Thanks to all the people who helped me in this great adventure. 
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8. Appendix 
 
8.1. Abbreviations 
 
A   
AD : Axial Diffusivity 
ADC : Apparent Diffusion Coefficient 
ANCOVA : Analysis of Covariance 
ARRA : American Recovery and Reinvestment Act 
B   
BET : Brain Extraction Tool 
BWH : Brigham And Women’s Hospital  
C   
CHB : Children’s Hospital Boston  
CITI : Collaborative Institutional Training Initiative 
CSF : Cerebrospinal Fluid 
CT : Computed Tomography 
D   
DICOM : Digital Imaging and Communications in Medicine 
dMRI : Diffusion Magnetic Resonance Imaging 
DTI : Diffusion Tensor Imaging 
DW : Diffusion Weighted 
DWI : Diffusion Weighted Imaging  
E   
EMPI : Enterprise Master Patient Index 
F   
FA : Fractional Anisotropy 
FDA : Food and Drug Administration 
FIT : Fractional Intensity Threshold 
FLAIR : FLuid Attenuated Inversion Recovery 
FSL : FMRIB Software Library 
G   
GLM : General Linear Model 
H   
HIPAA : Health Insurance Portability and Accountability Act 
HIV : Human Immunodeficiency Virus 
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I   
i2b2 : Informatics for Integrating Biology and the Bedside 
IRB : Institutional Review Board 
M   
MD : Mean Diffusivity 
MGH : Massachusetts General Hospital  
Mi2b2 : Medical Imaging Informatics Bench to Bedside 
MR : Magnetic Resonance 
MRI : Magnetic Resonance Imaging 
MRN : Medical Record Number 
P   
PACS : Picture Archiving and Communication System 
PET : Positron Emission Tomography 
PHRC : Partners Human Research Committee 
PI : Principal Investigator 
PLIC : Posterior Limb of the Internal Capsule 
R   
RD : Radial Diffusivity 
RDS : Radiological Decision Support 
ROI : Region Of Interest 
RPDR : Research Patient Data Registry 
S   
sCC : Splenium of the Corpus Callosum 
SCP : Service Class Provider 
SCU : Service Class User 
SNR : Signal to Noise Ratio 
SQL : Structured Query Language 
STD : STandard Deviation 
T   
TE : Echo Time 
TR : Repetition Time 
U   
US : Ultrasound 
V   
VB : Visual Basic 
W   
WBA : Whole Brain Average 
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8.2. Figures and Tables 
 
8.2.1. Figures 
 
FIGURE 1: PATIENTS ARE SCANNED IN THE HOSPITAL (1) AND MRI DATA ARE STORED IN PACS (2). RADIOLOGISTS ACCESS THE IMAGES AND 
THEIR RESULTING OBSERVATIONS (AS WELL AS ALL MEDICAL INFORMATION REGARDING PATIENTS) ARE STORED AND ORGANIZED IN RPDR 
(3). THE RPDR QUERY ALLOWS THE RETRIEVAL OF THIS MEDICAL INFORMATION IN MICROSOFT ACCESS DATABASE FORMAT (4).  THIS 
DATABASE IS USED TO IDENTIFY PATIENTS MEETING CERTAIN CRITERIA (5) AND THE CORRESPONDING LIST OF IDENTIFIERS IS SENT TO 
MI2B2 SOFTWARE IN ORDER TO RETRIEVE THE RELATED IMAGES (6). THE BB-PIPELINE THEN AUTOMATICALLY ORGANIZES THE DATA (7) 
AND EXTRACTS TECHNICAL INFORMATION THAT IS ADDED TO THE ACCESS DATABASE (8). THE RESULTING DATABASE IS USED TO PRECISELY 
IDENTIFY AND SELECT COMPARABLE IMAGES WITH MODALITIES OF INTEREST (9) THAT ARE USED FOR FURTHER DATA ANALYSIS (10). ......3 
FIGURE 2: STANDARD SPIN-ECHO SEQUENCE WITH THE ADDITIONAL GRADIENT (THE OTHER GRADIENTS ALONG THE X, Y AND Z DIRECTIONS FOR 
SPATIAL ENCODING ARE OMITTED FOR SIMPLIFICATION). THE B-VALUE IS AN EXPERIMENTAL PARAMETER WHICH DEPENDS ON THE 
LENGTH, HEIGHT AND TIMING OF THE DW GRADIENT. ........................................................................................................4 
FIGURE 3: WHEN MOLECULES OF WATER DIFFUSE ALONG THE DIRECTION OF THE GRADIENT (HORIZONTAL YELLOW ARROWS), A LOSS IN PHASE 
COHERENCE IS NOTICED AFTER THE REPHASING STEP. ..........................................................................................................4 
FIGURE 4: MYELIN, CELL MEMBRANE AND MICROTUBULES/NEUROFILAMENTS RESTRICT WATER DIFFUSION IN PERPENDICULAR DIRECTIONS 
LEADING TO LESS SIGNAL ATTENUATION. ......................................................................................................................... 5 
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FIGURE. ................................................................................................................................................................ 43 
TABLE 4: SCAN DETAILS ABOUT A PARTICULAR STUDY. MAGNETIC FIELD STRENGTH IS DISPLAYED IN MT, TR AND TE IN MS, ROWS, COLUMNS, 
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8.3. People 
 
Bill Wang, MSc, is a Systems Programmer of Partners Healthcare.  He is responsible for design, 
implementation, quality assurance, and support of mi2b2 project.  
 
Chris Herrick, MBA, is a Corporate Manager for Research Computing at Partners Healthcare. Chris manages 
the Medical Imaging Informatics Bench to Bedside (mi2b2) project and the Partners' Pharmacovigilance 
and Comparative Effectiveness initiative. He also serves as technical architect, project manager and liaison 
for various collaborators. 
 
Ellen Grant, MD, is the Director of the Fetal-Neonatal Neuroimaging and Developmental Science 
Center at Children’s Hospital Boston. She is an expert in pediatric neuroimaging and is currently 
involved in several projects including the development of new pediatric hardware (multichannel 
head coil and motion insensitive pulse sequence) and multimodality approach to estimating 
newborn brain oxygen metabolism in the context of perinatal brain injury. For many years before 
joining Children’s Hospital she worked at MGH and thus knows a lot about the pediatric 
neuroimaging data acquired there.  
 
Lilla Zollei, PhD, is working at Martinos Center on various medical image data registration projects 
mostly in pediatric populations, including surface and volumetric registration of brain MRI image 
and Diffusion Tensor Imaging (DTI) alignment. She is currently working on the development of 
novel representation and computational tools that will establish an age-dependent 4D atlas and 
analytic scheme to better understand normal brain development as well as examine the effects 
of premature birth. 
 
Randy Gollub, MD, PhD, is the director of the “Laboratory for Neuroimaging Applications to Pain, 
Acupuncture and Placebo Research”. This lab works in tight collaboration with many groups from 
different departments within the Martinos Center, the Psychiatric Neuroimaging Research 
Program, and across the country, to perfect the development and implementation of imaging 
technologies, especially in the domain of neuropsychiatric disorders.  
More specifically, Dr. Gollub’s team is focused on investigating the neuronal mechanisms 
underlying pain perception and its modulation by expectancy, placebo, and acupuncture 
treatment34. 
Besides her principal field of investigation, Dr. Gollub is involved and actively participates in a 
multitude of other interesting projects, notably the on-going Medical Imaging Informatics Bench 
to Bedside (mi2b2) project which is building the infrastructure necessary to make imaging data at 
multiple sites available to clinical translational investigators with appropriate human subject and 
institutional protections35,36. 
 
Rudolph Pienaar, PhD, is the Technical Director of the Fetal-Neonate NeuroImaging Development 
Science Center at Children’s Hospital and is responsible for the underlying technical 
                                               
34 http://www.nmr.mgh.harvard.edu/martinos/flashHome.php 
35 Mi2b2 project grant application 
36 http://www.na-mic.org/Wiki/index.php/CTSC:ARRA_supplement 
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infrastructure. He is also engaged in more basic research centered around MRI analysis, 
particularly as it pertains to pediatric brain development and pathology. 
 
Shawn Murphy, MD, PhD, is the Associate Director of the Laboratory of Computer Science (LCS) in 
the Clinical and Research Informatics Division of the Department of Medicine at MGH and an 
Assistant Professor of Neurology at Harvard Medical School. His current projects include 
Informatics for Integrating Biology and the Bedside (i2b2), RPDR and he is also the co-PI of mi2b2 
project.  
 
Taowei David Wang, PhD, is an application analyst in the Research Computing group of Partners 
HealthCare’s Information Systems department.  He is primarily interested in human-computer 
interaction and information visualization. His current projects include mi2b2’s user interface 
development. 
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8.4. Brain MRI procedures in RPDR 
 
Name Code_Type Code 
Magnetic resonance imaging, brain, functional MRI; including test selection and administration of 
repetitive body part movement and/or visual stimulation, not requiring physician or psychologist 
administration 
CPT 0.32 
CT or MRI of the brain performed within 24 hours of arrival to the hospital CPT 1.1 
CT or MRI of the brain performed greater than 24 hours after arrival to the hospital for patients aged 18 
years and older with an admitting diagnosis of ischemic stroke or TIA or intracranial hemorrhage 
CPT 1.18 
computer assisted sugery with MR/MRA ICD 88.41 
Presence or absence of hemorrhage, mass lesion, and acute infarction documented in final CT or MRI 
report 
CPT 88.91 
3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, 
ultrasound, or other tomographic modality; not requiring image postprocessing on an independent 
workstation 
CPT 88.96 
3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, 
ultrasound, or other tomographic modality; requiring image postprocessing on an independent 
workstation 
CPT 88.97 
Coronal, sagittal, multiplanar, oblique, 3-dimensional and/or holographic reconstruction of computerized 
axial tomography, magnetic resonance imaging, or other tomographic modality 
CPT 92.11 
Magnetic resonance (eg, proton) imaging, brain (including brain stem); with contrast material(s) CPT 92.12 
Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material CPT 92.18 
Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed 
by contrast material(s) and further sequences 
CPT 61751 
Magnetic resonance (eg, proton) imaging, orbit, face, and neck; with contrast material(s) CPT 70336 
Magnetic resonance (eg, proton) imaging, orbit, face, and neck; without contrast material(s) CPT 70540 
Magnetic resonance (eg, proton) imaging, orbit, face, and neck; without contrast material(s), followed by 
contrast material(s) and further sequences CPT 70541 
Magnetic resonance (eg, proton) imaging, temporomandibular joint(s) CPT 70542 
Magnetic resonance angiography, head and/or neck with or without contrast material(s) CPT 70543 
Magnetic resonance angiography, head; with contrast material(s) CPT 70544 
Magnetic resonance angiography, head; without contrast material(s) CPT 70545 
Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) and 
further sequences CPT 70546 
Magnetic resonance angiography-Oncall OPA 70551 
Magnetic resonance guidance for needle placement (eg, for biopsy, needle aspiration, injection, or 
placement of localization device) radiological supervision and interpretation 
CPT 70552 
Magnetic resonance guidance for needle placement (eg, for biopsy, needle aspiration, injection, or 
placement of localization device) radiological supervision and interpretation CPT 70553 
Magnetic resonance guidance for, and monitoring of, tissue ablation CPT 70554 
Magnetic resonance imaging of brain and brain stem ICD 70554 
Magnetic resonance imaging of of brain-Oncall OPA 75650 
Magnetic resonance imaging of other and unspecified sites ICD 75665 
Magnetic resonance imaging, brain, functional MRI; including test selection and administration of 
repetitive body part movement and/or visual stimulation, not requiring physician or psychologist 
administration 
CPT 75671 
Magnetic resonance imaging-Oncall OPA 76375 
Magnetic resonance spectroscopy CPT 76376 
Other intraoperative magnetic resonance imaging ICD 76377 
Stereotactic biopsy, aspiration, or excision, including burr hole(s), for intracranial lesion; with computed 
tomography and/or magnetic resonance guidance CPT 76390 
Unlisted magnetic resonance procedure (eg, diagnostic, interventional) CPT 76393 
Unlisted nervous system procedure, diagnostic nuclear medicine CPT 76394 
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Brain imaging, complete study; static CPT 76498 
Brain imaging, complete study; with vascular flow CPT 77021 
Brain imaging, limited procedure; static CPT 78600 
Brain imaging, limited procedure; with vascular flow CPT 78601 
Brain imaging, vascular flow only CPT 78605 
Cerebral vascular flow CPT 78606 
Angiography, carotid, cerebral, bilateral, radiological supervision and interpretation CPT 78610 
Angiography, carotid, cerebral, unilateral, radiological supervision and interpretation CPT 78615 
Angiography, cervicocerebral, catheter, including vessel origin, radiological supervision and interpretation CPT 78615 
Arteriography of cerebral arteries ICD 78699 
Cerebral scan ICD 3110F 
Cerebral vascular flow CPT 3111F 
Diagnostic procedures on skull, brain, and cerebral meninges ICD 3112F 
Other diagnostic procedures on brain and cerebral meninges ICD ZNCS3 
Scan of other sites of head ICD ZSAV3 
Total body scan ICD ZTAH1-A 
 
 
8.5. HIV related diagnosis 
 
Name Code_Type Code 
Asymptomatic human immunodeficiency virus [HIV] infection status ICD V08 
HIV antibody tes-Oncall ODA DKNF1 
Acquired immune deficiency syndrome-Oncall ODA DJAA6 
Acquired immunodeficiency syndrome ICD 42.9 
AIDS related complex-Oncall ODA DJAY9 
AIDS-LMR 11 ICD 42 
HIV infection (symptomatic)-Oncall ODA DJBQ4-1 
HIV infection-Oncall ODA DJBQ4 
HIV positive-LMR 190 ICD 42 
Human immunodeficiency virus infection causing other specified infections ICD 42.1 
Human immunodeficiency virus infection with specified infections ICD 42 
Human immunodeficiency virus infection with specified malignant neoplasms ICD 42.2 
HIV exposure-Oncall ODA DJBF6 
HIV infection (symptomatic)-Oncall ODA DJBQ4-1 
HIV wasting-Oncall ODA BJAQ2 
Human immunodeficiency virus [HIV] counseling ICD V65.44 
Positive HIV antibody test-Oncall ODA DKNF1-1 
Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of 
unspecified site 
ICD 79.53 
Human immunodeficiency virus, type 2[HIV 2] ICD 79.53 
Nonspecific serologic evidence of human immunodeficiency virus [HIV] ICD 795.71 
Positive serological or viral culture findings for human immunodeficiency virus (HIV) associated virus (HTLV-
III/LAV) 
ICD 795.8 
HIV - - 
HIV Infection MDC 25 
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8.6. Complete list of tables received from RPDR 
 
Cardiology  
Contact Information 
Demographics 
Diagnoses - one row per diagnosis 
Discharge Summaries 
Encounters - Visit Information and Diagnoses included in one row (Billing Data only) 
Endoscopy  
HealthHistory - Newborn Data, LMR Health Maintenance, LMR Vital Signs 
LMR health maintenance 
LMR medications 
LMR outpatient notes- not available for Limited Data Sets 
LMR problems 
LMR vital signs 
Medications - one row per medication 
Microbiology Data 
Mrn -  A list of patient medical record numbers 
Operative Reports 
Pathology  
PEARAllergy - Allergy Data from PEAR (Partners Enterprise Allergy Repository) 
Procedures - one row per procedure 
Providers - Top three providers for each patient 
Pulmonary  
Radiology  
Transfusion  
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8.7. IMPRESSION notes assessing “normal” brains 
 
Age-appropriate MRI of the brain with no structural abnormality identified. 
MRI appearance of the brain is age appropriate 
MRI of the brain normal for corrected gestational age without evidence of prior injury. 
Negative exam 
No abnormality is seen on this unenhanced MRI of the brain 
No acute abnormality identified. 
No definite structural abnormality identified. 
No evidence of acute intracranial abnormality   
No evidence of diffusion weighted or gross FLAIR abnormalities. 
No evidence of focal mass lesion or cortical abnormality. 
No evidence of intracranial pathology 
No evidence of morphological abnormality.  Unremarkable Brain MRI. 
No evidence of structural abnormality, infarction or hemorrhage. 
No intracranial abnormality identified 
No intracranial structural abnormality by MRI 
No significant abnormality seen 
No structural abnormalitiy identified 
Normal  
Normal age-appropriate MRI of the brain 
Normal brain MRI 
Normal brain MRI for age 
Normal brain MRI without evidence of structural anomaly or other CNS abnormality. 
Normal brain. 
Normal contrast enhanced MRI of the brain 
Normal conventional MR appearance of the brain 
NORMAL EXAMINATION 
Normal findings. 
Normal MR appearance of the brain for the patient's age 
Normal MR evaluation of the brain. 
Normal MRI of the brain 
Normal MRI of the brain for age without evidence of structural abnormality. 
Normal MRI of the brain parenchyma 
Normal MRI study of the brain 
Normal myelination by MR imaging 
Normal non-contrast MRI of the brain. 
Normal nonenhanced MRI of the brain for age 
Normal pediatric brain MRI and MRV, with no acute pathology identified to account for the seizure. 
NORMAL PEDIATRIC BRAIN MRI WITH NO PATHOLOGY IDENTIFIED 
Normal study 
NORMAL STUDY FOR AGE 
Normal unenhanced MRI of the brain 
The brain appears normal. There is no evidence of a cortical dysplasia. 
The brain is normal for age. 
Unremarkable age appropriate MRI brain. 
Unremarkable brain MRI 
Unremarkable MR appearance of the brain.  No brainstem or cranial nerve abnormality identified. 
Unremarkable MRI brain. Myelination within normal limits of normal for age. 
Unremarkable MRI of the brain 
Unremarkable MRI of the brain with no evidence of intracranial mass or acute territorial infarction. 
Unremarkable nonenhanced MRI of the brain 
UNREMARKABLE STUDY 
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8.8. DICOM headers 
 
MRN Slice_Thickness InPlane_Phase_Encoding_Direction 
Quality_of_the_images Repetition_Time Flip_Angle 
Integrity_of_the_volume Echo_Time Variable_Flip_Angle_Flag 
Accession_Number Inversion_Time SAR 
Weight Number_Of_Average Patient_Position 
Study_ID Imaging Frequency Image_Position(Patient) 
Study_Date Imaged_Nucleus Image_Orientation(Patient) 
Institution_Name Echo_Number Frame_Of_Reference_UID 
Manufacturer Magnetic_Field_Strength Slice_Location 
Modality Spacing_Between_Slices Sample_Per_Pixel 
Study_Despcription Echo_Train_Length Photometric_Interpretation 
Series_Number Percent_Sampling Rows 
Series_Description Percent_Phase_FieldOfView Columns 
Group_Length Pixel_Band_Width Pixel_Spacing 
Image_Type Device_Serial_Number Bits_Allocated 
Scanning_Sequence Software_Version Bits_Stored 
Sequence_Variant Spatial_Resolution High_Bit 
Scan_Option Reconstruction_Diameter Pixel_Representation 
MR_Acquisition_Type Receive_Coil_Name Pixel_Padding_Value 
Sequence_Name Transmit_Coil_Name Window_Center 
Angio_Flag Acquisition_Matrix Window_Width 
 
8.9. Estimated parameters 
 
WBAADC: 
 
Linear:   xmhxf )(  
h=-5.12e-07 [mm2/s] ; m=0.00134 [mm2/s] 
 
Logarithmic: )ln()( xbaxf    
  a=0.001491 [mm2/s] ; b=-6.221e-05 [mm2/s]   
 
Biexponential: t
x
s
x
eqepxf  )(  
  p=0.0002419 [mm2/s] ; s=97.38 ; q= 0.001137 [mm2/s] ; t=1e+04   
 
WBAFA: 
 
Linear:   xmhxf )(  
h=8.154e-05 ; m=0.2491 
 
Logarithmic: )ln()( xbaxf    
  a=0.2246 ; b=0.009999   
 
Biexponential: t
x
s
x
eqepxf  )(  
  p=0.2953 ; s=2.551e+05 ; q=-0.05807 ; t=173.8   
